Source: http://www.google.fr/patents/US9277962
Timestamp: 2017-12-12 01:09:43
Document Index: 129971916

Matched Legal Cases: ['Application No. 2008214068', 'Application No. 2008275543', 'Application No. 2', 'Application No. 2', 'Application No. 2', 'Application No. 2', 'Application No. 200880005429', 'Application No. 201180009484', 'Application No. 11760294', 'Application No. 2', 'Application No. 2', 'Application No. 2012', 'Application No. 2011', 'Application No. 2843', 'Application No. 4341', 'Application No. 2009', 'Application No. 2009', 'Application No. 2011', 'Application No. 10']

Brevet US9277962 - Impedance mediated control of power delivery for electrosurgery - Google Brevets
A method of controlling electrosurgical power delivery is based on a comparison of sensed tissue impedance to various impedance threshold values. Energy is delivered to tissue in a sealing cycle as a series of pulses. A pulse has a profile with a preset energy starting value that increases at a ramping...http://www.google.fr/patents/US9277962?utm_source=gb-gplus-shareBrevet US9277962 - Impedance mediated control of power delivery for electrosurgery
Numéro de publication US9277962 B2
Numéro de demande US 13/637,533
Numéro PCT PCT/US2011/029958
Date de priorité 26 mars 2010
Autre référence de publication US8419727, US20110238062, US20130116678
Numéro de publication 13637533, 637533, PCT/2011/29958, PCT/US/11/029958, PCT/US/11/29958, PCT/US/2011/029958, PCT/US/2011/29958, PCT/US11/029958, PCT/US11/29958, PCT/US11029958, PCT/US1129958, PCT/US2011/029958, PCT/US2011/29958, PCT/US2011029958, PCT/US201129958, US 9277962 B2, US 9277962B2, US-B2-9277962, US9277962 B2, US9277962B2
Inventeurs Tim Koss, Miriam H. Taimisto, Roseanne Varner
Cessionnaire d'origine Aesculap Ag
Citations de brevets (661), Citations hors brevets (140), Référencé par (7), Classifications (14), Événements juridiques (1)
Impedance mediated control of power delivery for electrosurgery
US 9277962 B2
A method of controlling electrosurgical power delivery is based on a comparison of sensed tissue impedance to various impedance threshold values. Energy is delivered to tissue in a sealing cycle as a series of pulses. A pulse has a profile with a preset energy starting value that increases at a ramping rate to a preset end value. Sensed impedance data are monitored throughout each pulse and compared to each of an impedance threshold value for RF setpoint, an impedance threshold value for cumulative time, and an impedance threshold value for energy cutback. Based on sensed impedance during a pulse, the profile of a subsequent pulse can be modified. In the event of a high impedance event that reflects low tissue presence, energy may be cutback. A sealing cycle is stopped when a cumulative amount of time with an impedance value over the impedance cumulative time threshold value reaches a limit.
an RF generator configured to deliver energy through an electrosurgical device to a target tissue in a sealing cycle comprising a series of pulses, the series beginning with an initial pulse having a profile comprising a preset RF level start value that increases at a preset ramping rate to a preset RF end value; and
a comparator configured to compare sensed impedance values of the target tissue to each of three preset impedance threshold values, these threshold values comprising a first impedance threshold value for RF setpoint, a second impedance threshold value for cumulative time, and a third impedance threshold value for energy cutback, wherein the second impedance threshold value is higher than the first impedance threshold value, and the third impedance threshold value is higher than the second impedance threshold value;
wherein the RF generator is further configured to control the delivery of energy during the sealing cycle by responding to the comparison of the sensed impedance values to the first, second and third impedance threshold values,
wherein when the sensed impedance is greater than the second impedance threshold value, a cumulative timing function is initiated, which accumulates time toward a preset sealing cycle duration, and when such time reaches the preset sealing cycle duration, energy delivery ceases immediately.
2. The electrosurgical system of claim 1 wherein the system is configured to cease the sealing cycle when a cumulative time of tissue showing an impedance value over the second impedance threshold value reaches a preset sealing cycle duration limit.
3. The electrosurgical system of claim 1, wherein when the sensed impedance value at the end of a preceding pulse is less than the first impedance threshold value for RF setpoint, the system is configured to control the delivery of energy to the subsequent pulse such that it has the same pulse profile as that of the initial pulse.
4. The electrosurgical system of claim 1, wherein when the sensed impedance value at the end of a preceding pulse exceeds the first impedance threshold value for RF setpoint, the system is further configured to control the delivery of energy to the subsequent pulse such that it has an elevated profile.
5. The electrosurgical system of claim 1, wherein when the sensed impedance at any time during a pulse exceeds the third impedance threshold value for energy cutback, the system is configured to cut back energy delivery.
6. An electrosurgical method comprising:
delivering energy from an electrosurgical device to a target tissue in a sealing cycle comprising a series of pulses, the series beginning with an initial pulse having a profile comprising a preset RF level start value that increases at a preset ramping rate to a preset RF end value;
comparing sensed impedance values of the target tissue to each of three preset impedance threshold values, these threshold values comprising a first impedance threshold value for RF setpoint, a second impedance threshold value for cumulative time, and a third impedance threshold value for energy cutback, wherein the second impedance threshold value is higher than the first impedance threshold value, and the third impedance threshold value is higher than the second impedance threshold value;
controlling the delivery of energy during the sealing cycle by responding to the comparison of the sensed impedance values to the first, second and third impedance threshold values, wherein when the sensed impedance is greater than the second impedance threshold value, a cumulative timing function is initiated, which accumulates time toward a preset sealing cycle duration, and when such time reaches the preset sealing cycle duration, energy delivery ceases immediately.
7. The electrosurgical method of claim 6 wherein controlling the delivery of energy during the sealing cycle by responding to the comparison of the sensed impedance values to the first, second and third impedance threshold values comprises ceasing the sealing cycle when a cumulative time of tissue showing an impedance value over the second impedance threshold value reaches a preset sealing cycle duration limit.
8. The electrosurgical method of claim 6, further comprising recording a cumulative time within an ongoing sealing cycle during which the sensed tissue impedance value exceeds the second impedance threshold value for cumulative time.
9. The electrosurgical method of claim 6, further comprising sending sensed tissue impedance values to a processor throughout each pulse, each pulse being either a preceding pulse to a subsequent pulse or being a final pulse.
10. The electrosurgical method of claim 6, wherein when the sensed impedance value at the end of a preceding pulse is less than the first impedance threshold value for RF setpoint, the method further comprises controlling the delivery of energy to the subsequent pulse such that it has the same pulse profile as that of the initial pulse.
11. The electrosurgical method of claim 6, wherein when the sensed impedance value at the end of a preceding pulse exceeds the first impedance threshold for RF setpoint, the method further comprises controlling the delivery of energy to the subsequent pulse such that it has an elevated profile.
12. The electrosurgical method of claim 6, wherein when the sensed impedance at any time during a pulse exceeds the third impedance threshold for energy cutback, the method further comprises cutting back energy delivery.
13. The electrosurgical method of claim 12, wherein cutting back energy delivery comprises cutting back energy delivery immediately.
14. An electrosurgical method comprising:
delivering energy from an electrosurgical device to a target tissue site in a sealing cycle comprising a series of pulses, each pulse of a preset pulse duration, the series of pulses beginning with an initial pulse having an initial pulse profile comprising a preset RF level start value that increases to a preset RF end value during the pulse;
sensing tissue impedance values during each pulse, each pulse being either a preceding pulse to a subsequent pulse or being a final pulse;
controlling the delivery of energy during a sealing cycle such that;
a. a profile of a successor pulse relative to the profile of its preceding pulse has any of an identical profile or a higher energy profile, depending on a comparison of the impedance value shown by tissue during the first pulse against to a first preset impedance threshold value for RF setpoint,
b. energy is cutback during a pulse when the sensed impedance value exceeds a third preset threshold value for energy cutback; and
c. energy delivery ceases when a cumulative amount of time that sensed impedance has exceeded a second preset impedance threshold value for cumulative time has accumulated a preset sealing cycle duration limit,
wherein the second preset impedance threshold value is higher than the first preset impedance threshold value, and the third preset impedance threshold value is higher than the second preset impedance threshold value, and
wherein when the sensed impedance is greater than the second preset impedance threshold value, a cumulative timing function is initiated, which accumulates time toward a preset sealing cycle duration, and when such time reaches the preset sealing cycle duration, energy delivery ceases immediately.
15. The electrosurgical method of claim 14, wherein:
when the sensed impedance exceeds the first preset impedance threshold value for RF set point, the energy profile of the succeeding pulse exceeds the energy profile of the preceding pulse, and
when the sensed impedance is less than the first preset impedance threshold value for RF set point, the energy profile of the succeeding pulse is identical to the energy profile of the preceding pulse.
16. The electrosurgical method of claim 14, wherein the energy profile of a pulse comprises an RF start value, an RF end value, and a transition phase between the RF start value and the RF end value.
17. The electrosurgical method of claim 14, wherein a lowered pulse energy profile of a successor pulse, with respect to the preceding pulse, comprises any of a lowered RF start value, a lowered RF end value, or a lower rate of transition from the RF start value to the RF end value.
18. The electrosurgical method of claim 14, wherein a heightened energy pulse profile of a successor pulse, with respect to the preceding pulse, comprises any of a higher RF start value, a higher RF end value, or a higher rate of transition from the RF start value to the RF end value.
19. The electrosurgical method of claim 14, wherein the transition from the RF start value to the RF end value comprises any of a sloped transition or a stepped transition.
20. An electrosurgical method comprising:
delivering energy from an electrosurgical device to a target tissue in a sealing cycle comprising a series of pulses, each pulse of a preset duration, the series of pulses beginning with an initial pulse having a profile comprising a preset RF level start value that increases at a preset ramping rate to a preset RF end value;
sensing tissue impedance values throughout each pulse, each pulse being either a preceding pulse to a subsequent pulse or being a final pulse;
comparing the sensed impedance values to each of three preset impedance threshold values, these threshold values comprising a first impedance threshold value for RF setpoint, a second impedance threshold value for cumulative time, and a third impedance threshold value for energy cutback;
controlling the delivery of energy during the sealing cycle by responding to the comparison of the sensed impedance values to the first, second and third impedance threshold values, such that the sealing cycle ceases when the cumulative time of tissue showing an impedance value over the second impedance threshold value reaches a preset sealing cycle duration limit,
wherein the second impedance threshold value is higher than the first impedance threshold value, and the third impedance threshold value is higher than the second impedance threshold value, and
This application is a U.S. National Phase of PCT International Application No. PCT/US2011/029958 filed on Mar. 25, 2011, which claims the benefit of priority of U.S. application Ser. No. 12/907,646, now U.S. Pat. No. 8,827,992, filed on Oct. 19, 2010, which in turn is a continuation in part of U.S. application Ser. No. 12/748,229, now U.S. Pat. No. 8,419,727, filed on Mar. 26, 2010, the contents of all of the foregoing applications referred to in this paragraph being incorporated by reference herein for all purposes.
All publications and patent applications mentioned in this specification are herein incorporated by reference into the present application to the same extent as if each individual publication or patent application were indicated specifically and individually to be so incorporated.
The present disclosure relates to systems and methods for electrosurgical technology. More particularly, the technology relates to impedance-mediated control of power delivery for electrosurgical systems and methods for tissue sealing.
Biopolar electrosurgical instruments apply high radiofrequency (RF) electrical current to a surgical site to cut, ablate, or coagulate tissue. A particular application of these electrosurgical effects is to seal luminal structures, such as blood vessels or gastrointestinal sites, or tissue edges. A typical electrosurgical instrument takes the form of a pair of forceps, with electrodes positioned on both jaws of the forceps. In an electrosurgical procedure, the electrodes are placed in close proximity to each other as the jaws are closed on a target site such that the path of current between the two electrodes passes through tissue within the target site. The mechanical force exerted by the jaws and the electrical current combine to create the desired surgical effect.
By controlling the level of mechanical pressure applied by the jaws, the gap distance between electrodes, and the intensity, frequency, and duration of the electrosurgical energy applied to the tissue, a surgeon can coagulate, cauterize, or seal tissue toward a therapeutic end. A typical goal of controlling the delivery of electrosurgical energy, more particularly, is to apply no more and no less than the precise amount of energy required to create the desired effect within the targeted sealing site, while minimizing deleterious effects to tissue peripheral to the target site. As tissue absorbs energy, such as radiofrequency energy, its impedance of radiofrequency energy increases. This increase in impedance is generally considered to be a measure of the degree to which the tissue has been “processed” toward a therapeutic endpoint state. Embodiments of the presently disclosed systems and methods are directed toward using target tissue impedance as a feedback signal to appropriately control the level of energy applied to a targeted sealing site.
Embodiments of the provided electrosurgical systems and methods include delivering energy from an electrosurgical device to a target tissue in a sealing cycle in the form of a series of pulses, each pulse being of a preset duration. The series of pulses begins with an initial pulse having a profile comprising a preset RF level start value that increases at a preset ramping rate to a preset RF end value. The methods may further include sending sensed tissue impedance values to a processor, or more specifically, to an impedance comparator element within a processor, throughout each pulse. Each pulse is either a preceding pulse to a subsequent pulse or a final pulse in a sealing cycle. The methods may further include comparing sensed impedance values to each of three preset impedance threshold values, including an impedance threshold value for RF setpoint, an impedance threshold value for cumulative time, and an impedance threshold value for energy cutback. The methods may further include controlling the delivery of energy during the sealing cycle by responding to the comparison of the sensed impedance values to the impedance threshold values.
In particular embodiments, controlling the delivery of energy includes ceasing the sealing cycle when the cumulative time of tissue showing an impedance value over the impedance cumulative time threshold value reaches a preset sealing cycle duration limit. Embodiments of the electrosurgical method may further include recording the cumulative time within an ongoing sealing cycle during which the sensed tissue impedance value exceeds the impedance threshold value for cumulative time.
Based on these comparisons of sensed impedance data to the impedance threshold values, various electrosurgical operating consequences may occur. When the sensed impedance value at the end of a preceding pulse is less than the impedance threshold value for RF setpoint, the methods may further include controlling the delivery of energy to the subsequent pulse such that it has substantially the same pulse profile as that of the initial pulse. When the sensed impedance value at the end of a preceding pulse exceeds the impedance threshold for RF setpoint, the methods may further include controlling the delivery of energy to the subsequent pulse such that it has an elevated profile. Such an elevated pulse profile may include stepping up at the outset of the pulse directly to the RF end value. An elevated pulse profile may also include ramping up from the RF start value to the RF end value at a rate greater than that of the preceding pulse.
When the sensed impedance at any time during a pulse exceeds the impedance threshold for energy cutback, the methods may include cutting back energy delivery. Such energy cutback may occur immediately, or it may include waiting for a preset elapsed amount of time to accumulate during which the sensed impedance exceeds the impedance threshold for energy cutback before cutting back energy delivery (up to about 2 seconds, for example).
Cutting back energy delivery may also include lowering any of an RF delivery level or a ramping rate. Lowering the amount of energy being delivered may include decreasing the energy delivery by an amount between about 1 and about 100 volts. Alternatively, lowering the amount of energy being delivered may include decreasing the energy delivery by a fractional percentage of that which is being delivered. More particularly, lowering the amount of energy being delivered may comprise decreasing the energy delivery by a fractional percentage of the amount of energy proportional to the extent to which the sensed impedance exceeds the impedance threshold for energy cutback value.
With regard to pulse duration and the RF values of pulses, in various embodiments of the electrosurgical method, the RF pulses, typically, are each of a constant duration that may range from about 0.5 sec to about 10 sec. The number of pulses in the series of pulses may range from 1 pulse to about 30 pulses. In various embodiments of the electrosurgical method, the cumulative sealing endpoint duration is between about 0.1 sec and about 5 sec. In various embodiments of the electrosurgical method, the RF start value is in the range of about 25 watts to about 150 watts, and the RF End Value is in the range of about 50 watts to about 150 watts.
With regard to the aforementioned impedance thresholds, in various embodiments of the method, the impedance threshold for RF setpoint is in the range of about 5 ohms to about 250 ohms, the impedance threshold for energy cutback value is in the range of about 100 ohms to about 900 ohms, and the impedance threshold for cumulative time value is in the range of about 100 ohms to about 750 ohms.
With regard to the transition from an RF start value to the RF end value of a pulse, in various embodiments of the electrosurgical method, delivering energy includes increasing the level of energy being delivered from the preset RF start value to a preset RF end value during a pulse. In some embodiments, increasing the level of energy during a pulse includes ramping up at a rate that ranges between about 1 watt/sec and about 100 watts/sec. In some embodiments, increasing the level of RF energy during a pulse includes ramping up in one or more steps. In some embodiments, increasing the level of energy during a pulse may include ramping up at a constant rate or at a changing rate. In still further embodiments, increasing the level of energy during a pulse comprises stepping up immediately to a preset RF end value upon initiation of a pulse.
In another aspect, an embodiment of an electrosurgical method includes delivering energy from an electrosurgical device to a target tissue site in a sealing cycle that includes a series of pulses, each pulse having a preset pulse duration. The series of pulses begins with an initial pulse having an initial pulse profile comprising a preset RF level start value that increases to a preset RF end value during the pulse. This embodiment of the method further includes sending a sensed tissue impedance value to a processor during each pulse, each pulse being either a preceding pulse to a subsequent pulse or being a final pulse. This latter embodiment of the method further includes controlling the delivery of energy during a sealing cycle such that: (A) a profile of a successor pulse relative to the profile of its preceding pulse has any of an identical profile or a higher energy profile, depending on a comparison of the impedance value shown by tissue during the initial or preceding pulse against a preset impedance threshold value for RF setpoint, (B) energy is cutback during a pulse when the sensed impedance value exceeds a preset threshold value for energy cutback; and (C) energy delivery ceases when a cumulative amount of time that sensed impedance has exceeded a preset impedance threshold value for cumulative time has accumulated a preset sealing cycle duration limit.
Further with regard to this latter embodiment of an electrosurgical method, when the sensed impedance exceeds the preset threshold value for RF set point, the energy profile of the succeeding pulse exceeds the energy profile of the preceding pulse, and when the sensed impedance is less than the preset threshold value for RF set point, the energy profile of the succeeding pulse is identical to the energy profile of the preceding pulse.
With respect to embodiments of an electrosurgical method, the energy profile of a pulse includes an RF start value, an RF end value, and a transition phase between the RF start value and the RF end value. In these embodiments, a lowered pulse energy profile of a successor pulse, with respect to the preceding pulse, may include any of a lowered RF start value, a lowered RF end value, and/or a lower rate of transition from the RF start value to the RF end value. A heightened energy pulse profile of a successor pulse, with respect to the preceding pulse, may include any of a higher RF start value, a higher RF end value, and/or a higher rate of transition from the RF start value to the RF end value. And finally, the transition from the RF start value to the RF end value comprises any of a sloped transition and/or a stepped transition.
FIG. 1 is a block schematic diagram of a system for impedance-mediated RF power delivery for electrosurgery according to an embodiment of the disclosed technology.
FIG. 2 is a schematic representation of impedance thresholds against which sensed impedance values may be compared and consequent responses with regard to RF energy delivery during an electrosurgical sealing cycle.
FIG. 3 is a flow diagram showing aspects of the disclosed method for using sensed impedance as feedback data to control delivery of RF energy during an electrosurgical sealing procedure.
FIG. 4 is a flow diagram showing aspects of a system and method for using sensed impedance as feedback data to control delivery of RF energy during an electrosurgical sealing procedure.
FIG. 5 is a timing diagram showing an example of impedance-mediated control of a power delivery ramp for electrosurgery according to an embodiment of the method.
FIG. 6 is a timing diagram showing an alternative example of impedance-mediated control of power delivery interval for electrosurgery according to an embodiment of the method.
FIG. 7A is a timing diagram showing an RF power delivery profile as controlled by tissue impedance feedback according to an embodiment of the method.
FIG. 7B is a timing diagram showing a tissue impedance profile during energy delivery according to an embodiment of the method.
FIG. 8 is a timing diagram showing a tissue impedance profile during energy delivery as modified by the occurrence of a rapid rise in impedance that is indicative of low tissue presence in the RF circuit path.
The electrosurgical tissue sealing technology provided herein relates to applying the dynamics of the response of tissue to RF energy as feedback information to control the delivery of the energy during an electrosurgical procedure. Tissue sealing that is surgically optimal occurs when an appropriate level of energy is delivered to a target site at an optimal rate; too much energy, or energy delivered too quickly can damage the target site and surrounding tissue, and too little energy does not create a high integrity seal. Another consideration is that the effects of absorbing a given quantity of energy by a tissue sealing site is a function of the specifics of tissue type and total tissue volume receiving energy, both of which are variables at play in each sealing procedure. As tissue is being impacted or “processed” by RF energy, such as by coagulation, desiccation, or fulguration, or any combination thereof, impedance of the tissue to electrical current increases. The change in impedance is generally ascribed to a change in the “phase” or “state” of the tissue.
The relationship between energy input and the rate of change in the tissue state is affected by factors such as tissue composition, tissue density, water content, and electrolyte content. In these terms, an optimal rate of RF energy delivery is one that drives the change in tissue phase, as reflected in the rate of increase in impedance, at an optimal rate. The optimal rate of change in impedance can be learned empirically, from experimental and clinical experience. Accordingly, and as provided by embodiments of the method, the sensed change in tissue impedance during an electrosurgical procedure is an advantageous parameter to use as feedback in governing the rate of RF energy delivery to a targeted sealing site. A theoretical rationale of the method is offered to support of an understanding of its operation, but without any characterization that would limit claims to the method. It is considered advantageous to recognize when tissue is processing slowly, and, in response, to deliver energy to the tissue slowly. And, when tissue is processing quickly, in response, it is advantageous to deliver energy to the tissue quickly. The system is thus balanced so as to direct energy to a target site no more quickly than it can absorb the energy through tissue processing. Thus tissue is processed efficiently to an appropriate endpoint, and the spread of excess energy beyond the targeted tissue sealing site is minimized.
As described further below, impedance threshold values may be used to control the delivery of RF energy in a sealing cycle comprising a series of energy pulses delivered to a targeted tissue site. Sensed impedance may used to variously control energy delivery in real time, as during a pulse, or in a prospective manner, by controlling the delivery of energy in a succeeding pulse, as well as by terminating an energy delivery cycle at any point during a pulse.
FIG. 1 is a block schematic diagram of a system for impedance-mediated power delivery for electrosurgery according to the disclosed technology. Although the description, examples, and figures of the present disclosure relate primarily to aspects of a method for electrosurgical tissue sealing, embodiments of the technology also include a system and any subset of its components that are adapted or configured to operate per embodiments of the method. In FIG. 1, a procedure in which electrosurgery is being performed on the target tissue 10 of a patient by an electrosurgical device 12. A source of energy, such as a radiofrequency (RF) generator 18 is coupled to the electrosurgical appliance by a control circuit 16. In some embodiments, the control circuit is operable to adjust any of the current and voltage output and, thereby to adjust the power output of the RF generator. The control circuit can also adjust the RF generator output up or down in steps or it can ramp up or down at a selected slope during a pulse.
Embodiments of the method and systems for operating method embodiments provided herein are suitable for both single channel and multiple channel electrosurgical system operation. Multi-channel systems typically include an RF generator with multiple outputs coupled to multiple electrodes or electrode pairs. In multi-channel systems that make use of the embodiments of the method described herein, a generator may be capable of addressing electrodes individually and independently, such that electrode firing may occur without constraint with respect to repetition of individual electrode firing or with respect to the sequential order of adjacent electrode firing. In other words, the firing parameters of each electrode may be based on settings and/or feedback associated solely with that electrode.
The effect of the electrosurgical device on the tissue is monitored at the site of tissue treatment by one or more sensors associated with the electrosurgical appliance. A signal produced by the one or more sensors is coupled to a sensor circuit 14. The sensors can monitor environmental factors and operating parameters such as temperature, impedance, RF voltage, RF current, elapsed time, and the like. In particular embodiments, at least some of the sensors monitor the parameters of tissue impedance and RF power.
A sensor circuit 14 generates an output signal that is conveyed to a processor 15. The processor, operating under control of a program per aspects of the presently described method, is configured to adjust the output of the RF generator by issuing control signals to the control circuit. In doing so, the processor may adjust the RF power delivered to the tissue in real time, in response to signal generation by the sensors. The program may be retained in a memory 17 and includes both instructions for operating the processor and parameters that determine how to respond to signals from the sensor, timing, and other information as may be utilized to control the delivery of energy per aspects of the method.
As the tissue is processed by application of energy, a phase or state change occurs in the tissue that, in turn, causes a change in the impedance of the tissue. A particular feature of the provided technology is the manner in which the processor operates the control circuit and, thus, the manner in which energy is supplied to the tissue, in response to signals provided to the processor from one or more types of sensors, such as impedance sensors, via sensor circuitry.
More particularly, embodiments of the method apply sensed impedance to changing aspects of the profile of an electrosurgical pulse, components of a profile include an initial RF start value, an RF end value, and either a step-wise or ramped increase in RF delivery over the course of the pulse from the RF start value to the RF end value. As used herein, a “ramp” of energy output refers to the difference between the output level at the start of a pulse of energy delivery and the output level achieved at the end of the pulse, while “slope” refers more specifically to the rate at which the energy output changes over time during the pulse. Energy is typically delivered in a series of pulses that may be of a preselected or preset constant duration, although in some embodiments of the, the pulses may vary in length.
Embodiments of the electrosurgical system and method monitor the sensed impedance that target tissue manifests when being exposed to a pulse of RF energy and compares impedance data to various preset impedance threshold values during a sealing cycle that includes a series of pulses. Embodiments of the system and method respond to these comparisons by variously adjusting the profile of the ongoing pulse, adjusting the profile of the immediately succeeding or subsequent pulse, and by tracking time toward a cumulative sealing cycle endpoint duration, at which point the sealing cycle is terminated. These various system responses, collectively, represent a method for controlling aspects of the performance of an electrosurgical system during a sealing cycle, including the amount of power delivered during individual RF pulses, and during the sealing cycle as a whole.
These impedance threshold values include an impedance threshold value for an RF setpoint, an impedance threshold value for cumulative sealing cycle duration timing, and an impedance threshold value for energy cutback. Although the impedance values for each of these three threshold values include regions of overlap, the thresholds within typical embodiments of the method are ordered such that the impedance threshold value for an RF setpoint is the lowest threshold value, the impedance threshold for cumulative sealing cycle duration is the intermediate threshold value, and the impedance threshold value for energy cutback is the highest threshold value. These impedance threshold values and their roles in controlling energy delivery are detailed and described further below. Tables 1 and 2, as well as FIGS. 2, 3, and 4, provide overviews of aspects of the method, with particular attention to ways in which impedance data are fed back into the processor and used to control energy delivery to a targeted sealing site.
In one aspect, embodiments of the impedance-based power control method relate to controlling the profile of individual pulses within a series of pulses. Radiofrequency pulses, as delivered by embodiments of the method, have profile that includes a preset RF start value and a preset RF end value, typically higher than the RF start value. During the course of a pulse, the RF energy typically increases from the start value to the end value at a preset rate. In some pulses, per response to threshold impedance values as described further below, a pulse may step directly from the start value to the end value. Each of these parameters of a pulse profile is typically preset for a particular tissue sealing cycle, but each parameter may be adjustable within a range of values. The RF start value may range between about 25 and about 150 watts; a typical value, by way of example, is about 50 watts. The RF end value may range between about 50 and about 150 watts; a typical value, by way of example, is about 150 watts. The ramp rate or slope by which energy may increase from the RF start value to the RF end value may range between about 1 watt/sec and about 100 watts/sec; a typical value, by way of example, is about 50 watts/sec.
The impedance threshold value for RF setpoint is typically the lowest of the three impedance thresholds. This performance control mediating threshold has a preset value that ranges between about 5 and about 250 ohms; a typical value, by way of example, is about 50 ohms. Some embodiments of the system are configured to compare the tissue impedance at the conclusion of a pulse (or at its maximum) to this threshold value and to direct the profile of the succeeding pulse into one of two paths, depending on whether the pulse end impedance falls below or exceeds the RF setpoint threshold value. In the event that the end-pulse impedance (of a preceding pulse) is less than this threshold, the succeeding pulse is operated with the same profile as the preceding pulse.
In the event that the end-pulse impedance (of a preceding pulse) exceeds the impedance threshold value for RF setpoint, the succeeding pulse may be operated with a higher energy level profile. An elevated energy profile may occur by any approach that increases the integrated value of pulse duration multiplied by power; for example, in one embodiment, the pulse may initiate with the RF start value and then step directly (without an attenuated ramp) to the RF end value. In other embodiments, the slope of the energy delivery during the pulse may increase. In still other embodiments, the RF start value or the RF end value may be increased.
The impedance threshold value for cumulative sealing time duration is typically higher than the RF setpoint threshold value. In some embodiments, this performance control-mediating threshold has a preset value that ranges between about 100 ohms and about 750 ohms; a typical value, by way of example, is about 250 ohms. During the course of an electrosurgical procedure, as delivered by a series of pulses per aspects of the method, the impedance of target tissue increases. This increase is understood to be generally reflective of a tissue “processing” by RF energy to a level appropriate to serve a particular therapeutic end. Thus, the impedance shown by tissue may be considered a marker of tissue processing, and an optimal level of processing may be considered that rendered by absorbance of an optimal level of RF energy for an optimal duration of time. Accordingly, the system and method may be directed to record accumulated time at an impedance threshold value for cumulative time duration, which, upon being reached, causes the delivery of RF energy to cease. Cessation of energy delivery may occur immediately during an RF pulse upon accumulation of a preset sealing time duration. The cumulative sealing endpoint duration, per embodiments of the method, may range between about 0.1 sec and about 5 sec.
The impedance threshold value for energy cutback is typically the highest of the three impedance thresholds. This performance control-mediating threshold has a preset value that ranges between about 100 ohms and 900 ohms in some embodiments; a typical value, by way of example, is about 700 ohms. A high impedance level (see FIG. 8) reading during an RF pulse may be considered to be a consequence of low tissue presence in the electrosurgical space between the forceps of a device. It is, after all, tissue that is allowing conductance of RF energy between the forceps. In the complete absence of tissue, impedance within the circuit is absolute or infinite in practical terms. In the presence of low tissue, impedance is not infinite, but can quickly become very high. Low tissue presence may occur if, for example, tissue, or a portion thereof is particularly thin, compared to a typical amount of target tissue between the forceps. Or, there may be spaces between the forceps tips where tissue is simply absent. The electrosurgical system may respond to the high impedance event by cutting back on the level of energy delivery. Embodiments of the system thus include a timer that is configured to record the amount of time the tissue is manifesting this high impedance level, and upon accumulation of a preset amount of accumulated time, the system responds by cutting back on the amount of energy being delivered.
The energy cutback, per embodiments of the method, occurs by decreasing the profile of energy pulses being delivered. Such energy cutback may occur immediately, at any point during a pulse, when the impedance threshold for energy cutback is exceeded. In alternative embodiments of the method, energy cutback may occur after the passage of a preset delay. In still other embodiments, the energy cutback may be initiated in a succeeding pulse. The amount of energy cutback may occur by way of cutting back on level of energy delivery, or by way of decreasing the rate of energy increase during a pulse. Any one or more of several approaches may adjust the level of energy delivery downward. For example, the energy delivery may be dropped by an absolute amount of wattage or voltage. Alternatively, the level of energy delivery may be dropped by a fractional percentage of the level of energy being delivered at the moment when the impedance threshold for energy cutback is exceeded. In another variation, the level of energy delivery may be dropped by the fractional portion that corresponds to the difference between the sensed impedance and the impedance threshold for RF energy cutback. It can be noted, merely for the purpose of understanding the rationale of aspects of the method, that an exceptionally fast increase in impedance which includes exceeding the impedance threshold for energy cutback is indicative of a small amount of tissue, rather than a normal amount of tissue, absorbing all of the delivered energy, and thus being processed more quickly than is desired.
FIG. 2 provides a schematic outline of the three impedance thresholds used in aspects of the method to control the delivery of energy during an electrosurgical procedure, and consequences that follow from sensed impedance data being delivered back to system components that control the delivery of energy. The impedance thresholds are arranged on the left side of the figure, aligned against an axis of ascending ohm values. Impedance threshold 1 pertains to the RF setpoint, impedance threshold 2 relates to cumulative time, and impedance threshold 3 relates to energy cutback. The right side of the figure shows the energy delivery consequences to impedance values sensed during a pulse, as they fall into ranges bracketed by these thresholds. These energy delivery consequences pertain either to a pulse following the preceding pulse (during which time the sensed impedance occurred) or to immediate, real-time, consequences to energy delivery during the pulse.
Continuing with FIG. 2, starting with the lowest threshold, the impedance threshold for RF setpoint, the bracketed segment 201 on the right side of the figure shows that a sensed impedance value (typically the impedance at the conclusion of a time pulse) that falls at or below this threshold causes the profile of energy delivery in the subsequent pulse to remain the same or be decreased. Such decrease may be a one-time event, after which the profile remains constant, or such decrease may continue with each successive pulse. As noted above, a profile may decrease either by way of downward adjustment of RF setpoints, or by diminishing the rate by which RF energy increases during the pulse.
Continuing with FIG. 2, ascending from the lowest bracketed segment 201, the next bracketed segment 202 extends upward from the impedance for RF setpoint to the impedance threshold for energy cutback. The right side of the figure notes that the profile of the energy pulse that follows a preceding pulse where the sensed impedance (typically the impedance at the conclusion of a time pulse) has fallen into this segment is delivered with an elevated profile. Such increase may be a one-time event, thereafter which the profile remains constant, or such increase may continue with each successive pulse. As noted above, a profile may increase either by way of upward adjustment of RF setpoints, or by increasing the rate by which RF energy increases during the pulse.
Continuing further with FIG. 2, a bracketed segment 203 extends above the threshold for energy cutback toward maximal impedance. The consequence of a sensed impedance value occurring at any point during a pulse falling into this bracketed range is that energy delivery is cutback, while the pulse is ongoing. In some embodiments, energy is cutback immediately; in other embodiments, energy is cutback after a delay of up to seconds. This delay, if implemented, is for the purpose of validating that the high impedance event is real and sustaining, not due to a transient or erroneous signal from an impedance sensor.
Finally, with regard to FIG. 2, a large bracketed segment 204 embraces sensed impedance values that range upward from the impedance threshold for cumulative time. As sensed impedance values rise above this threshold, a timer is initiated that runs as long as impedance is above this threshold value. If impedance falls below this threshold value, as it may when energy is cutback, the timer ceases accumulating time. As impedance then may rise again to surpass the threshold, the timer again accumulates time. Upon the accumulation of a preset cumulative time duration for the sealing cycle, energy delivery during the cycle ceases.
FIG. 3 is a flow diagram that shows elements of a method for using sensed impedance as feedback data to control delivery of RF energy during an electrosurgical sealing procedure. In an initial step 198, energy is delivered to a target tissue site in a series of pulses, each pulse having a profile that may or may not be adjusted in response to sensed impedance data in the subsequent pulse. In a second step 199, sensed impedance data are sent to an impedance threshold comparator within the system. In a third step 200, sensed impedance data are compared to an impedance threshold (1) for the RF setpoint, an impedance threshold (2) for cumulative timing of the preset sealing cycle duration, and (3) an impedance threshold (3) for energy cutback at any time during a pulse.
As a result of these comparisons ongoing within the comparator (FIG. 3), any one of several consequences may follow. In the event 201 that sensed impedance is less than impedance threshold 1, the profile of the subsequent pulse is either maintained or decreased. In the event 202 that sensed impedance is greater than impedance threshold 1, the profile of the subsequent pulse is either maintained or increased. In the event 203 that sensed impedance is greater than impedance threshold 2, a cumulative timing function is initiated, which accumulates time toward a preset sealing cycle duration. When such time reaches the preset sealing cycle duration, energy delivery ceases immediately. In the event 204 that sensed impedance is greater than impedance threshold 3, energy delivery is cutback either immediately during the instant pulse, or cutback after a short delay to serve the purpose of validating the high impedance incident.
FIG. 4 is a flow diagram showing aspects of a method and system for using sensed impedance as feedback data to control delivery of RF energy during an electrosurgical sealing procedure. Aspects of the method draw upon a library and adjuster 100 of RF pulse profiles that includes an initial profile 101, an elevated profile 102, and a lowered profile 103. The initial profile is preset; the values of parameters RF start value, RF end value, and the transition between the them (slope or step) can all vary within their respective ranges, as shown in Table 1. The parameters of the lowered and elevated profiles also vary per the ranges of Table 1, with the qualification that the profiles as a whole, are either lower or higher, respectively, than the parameters of the initial pulse profile 101.
Prior to the delivery of an RF pulse, an RF pulse selector 110 selects which pulse profile in the profile library (101, 102, or 103) to deliver to tissue 150. The pulse selector 110 makes the selection based on input from a threshold comparator 170 (see further, below). The RF pulse selector 110 has an output that drives the setpoint for the RF energy generator 120, which delivers an RF energy pulse 140 that is ultimately directed to a target tissue site 150. As energy is being delivered it passes through an intervening mechanism in the form of an RF energy attenuator or cutback block 130 that can attenuate the energy delivery, in real time, based on data from the threshold comparator 170.
The target tissue site 150 is both the recipient of RF energy 140 being delivered by the system via electrosurgical forceps 145, as well as the source for impedance data 160 that are conveyed back to the system, stored in a memory and processed by a processor, as represented by a threshold comparator 170. The threshold comparator performs constant surveillance of sensed impedance data from the target tissue and compares these data against three particular impedance thresholds, as outlined in FIG. 2, and as described further below in an outlined summary of an embodiment of the method.
Briefly, these impedance thresholds include an impedance threshold for the RF setpoint 171, an impedance threshold for pulse duration cumulative timing 172, and an impedance threshold for energy cutback 173. It can be seen that the result of a comparison 171 of impedance data with respect to an RF setpoint threshold value is directed into the profile selector and adjuster 110, which then typically assigns either an elevated profile 102 or a lowered profile 103 for the subsequent pulse in response to the incoming data. The result of the comparison 172 of impedance data with respect to an impedance threshold for cumulative time is directed to the RF energy generator/delivery block 120; if the cumulative time is less than the preset duration, block 120 is enabled to generate RF energy. When the cumulative time achieves the preset sealing cycle duration, further delivery of energy from block 120 is stopped. The result of the comparison of impedance data with respect to an impedance threshold of energy cutback 173 is directed into the RF energy attenuator cutback block 130. If data from impedance comparison 173 indicates that the impedance is less than the impedance threshold for energy cutback, energy delivery proceeds without attenuation. If data from impedance comparison 173 indicates that the impedance exceeds the impedance threshold for energy cutback, energy delivery proceeds with attenuation in real time.
In some embodiments, in response to tissue impedance exceeding the impedance threshold for energy cutback, energy is cutback by an amount proportionate to the total amount of energy being delivered during the high impedance event. The fractional amount by which energy is cutback, in some embodiments, may be related to the proportional amount by which the sensed impedance is exceeding the impedance threshold for energy cutback. For example, if the impedance threshold for energy cutback is 300 ohms and sensed impedance is 450 ohms (50% greater than the impedance threshold of 300 ohms), the energy delivery may be cutback by 50%. In some embodiments of this proportional energy cutback procedure, the cutback is performed in a continuous real time manner, with the response to energy cutback immediately tracking the extent to which sensed impedance exceeds the threshold for energy cutback.
Table 1 summarizes the values of various parameters associated with the delivery of radiofrequency energy and the sensed target tissue impedance during an electrosurgical tissue sealing procedure, in accordance with aspects of the disclosed methods. The specific value drawn from within range (for RF values and impedance thresholds) is typically preset and fixed for any given electrosurgical procedure, however these preset values are adjustable within the range.
Radiofrequency Sealing Method Parameters
Parameter Example Typical Range
RF Pulse Time Parameters
RF Pulse Duration 3.0 sec. 0.5-10.0 sec.
Max RF Pulse Count per sealing 5 pulses 1-30 pulses
Cumulative Sealing Endpoint 1.5 sec. 0.1-5.0 secs.
Duration Limit (total
time when impedance exceeds
endpoint timing threshold)
RF Levels and Ramping Rate
RF Start Value, initiating a pulse 50 watts 25-150 watt
RF End Value, at the end of a 150 watts 50-150 watt
RF Ramp Rate (or slope) 50 watt/ 1-100 watt/sec.
during a pulse sec.
Tissue Impedance Parameters
Pulse-end Impedance the tissue 2-900 ohms
Impedance Threshold (1) for RF 50 ohms 5-250 ohms
Setpoint (determining energy
parameters of next pulse)
Impedance Threshold (2) for 250 ohms 100-750 ohms
(cumulative time above this
value contributes to cumulative
sealing endpoint duration)
Energy cutback in response
to a high impedance event
Impedance Threshold (3) for 300 ohms 100-900 ohms
Energy Cutback
Energy Cutback Time 0.1 sec. 0-2.0 secs
Energy Cutback Fraction 50% Cutback energy by
(Cut energy delivery back 10%-90%
to a fractional portion of (to a level between
the energy being delivered 90% and 10% of pre-
at the point when the impedance cutback)
threshold is exceeded.)
Table 2 summarizes the profile of the RF pulse that follows a preceding pulse, as controlled by the sensed tissue impedance during the preceding pulse, as well as other system responses to sensed impedance values during an exemplary sealing cycle.
Subsequent Energy Delivery and Sealing Cycle Endpoint Consequences
to Sensed Tissue Impedance Response During Energy Delivery
Profile of the Consequences re Continued
Initial or Sensed Tissue Energy Delivery and
Preceding RF Impedance Cumulative Timing toward
pulse During RF Pulse Cycle Stop
The RF start A sensed end-pulse In the succeeding pulse,
value is at a impedance value that maintain same profile as that
preset initial is less than of the preceding pulse
value; it ramps impedance threshold
up at a preset (1) for RF setpoint
rate to a preset A sensed end-pulse In the succeeding pulse, step
RF end value impedance value that up immediately to the
exceeds impedance RF end value.
threshold (1) for RF
A sensed impedance A timer tracks the cumulative
value at any time time toward a sealing endpoint
during a pulse time duration which; when that
that exceeds duration is reached, the sealing
impedance threshold cycle stops
(2) for cumulative
timing duration
A sensed impedance Cutback of RF energy delivery
value at any time at any time during the cycle. If
during a pulse sensed impedance value again
that exceeds exceeds impedance threshold
impedance threshold (3), repeat cutback. In some
(3) for energy cutback, embodiments, the cutback is
indicative of low proportional to the amount of
tissue presence energy being delivered, and
operates in a continuous real
An embodiment of the method by which sensed impedance controls the delivery of RF energy during an electrosurgical tissue sealing cycle is summarized below.
1. Initiate a sealing cycle with a pulse at a preset initial RF Start Value; ramp up power at a preset initial RF ramp rate during the pulse until power reaches an RF End Value; continue at that power level for duration of a preset pulse duration, and then cease energy delivery to conclude the pulse.
2. Obtain sensed tissue impedance data continuously throughout the RF initial pulse and every subsequent pulse. All of the sensed impedance data are stored in a memory to which a processor has access. In various aspects of the method, sensed impedance data from any point during the pulse may be used as a value to compare to any one or more of three impedance threshold values. In some aspects of the method, the sensed impedance at the end of a pulse is a particular value used in comparison to impedance threshold values.
3. Continuously compare the sensed impedance values from all points during a pulse with respect to (a) an impedance RF setpoint threshold value, (b) an impedance threshold for cumulative timing threshold, and (c) an impedance energy-cutback threshold value. Take the sealing cycle forward in accordance with the following options (4A, 4B, 4C, or 4D), depending on the result of these comparisons.
4A. If, at the end of a preceding pulse, the sensed pulse end impedance value is less than the impedance threshold for RF Setpoint value, deliver energy during the subsequent pulse with a pulse profile substantially identical to that of the preceding pulse. The sealing cycle proceeds in this manner until a preset sealing time duration is achieved, as in 4C.
4B. If, at the end of a pulse, the sensed pulse-end impedance value is greater than the impedance threshold for RF Setpoint value, deliver energy during the subsequent pulse with a pulse profile higher than that of the preceding pulse. In some embodiments of the method, this increase in pulse profile occurs just once, during the pulse that follows the initial pulse. In some embodiments of the method, the pulse profile is increased by undergoing an immediate step up from the RF start value to the RF end value (rather than by way of a ramping increase, as typical of the initial pulse). The sealing cycle proceeds in this manner until a preset sealing time duration is achieved, as in 4C.
4C. If, at any time during any pulse, the sensed impedance exceeds an impedance threshold for cumulative sealing time, a timer is initiated that runs for a preset sealing time duration. If sensed impedance falls below this threshold, the cumulative timer stops recording time. Upon completion of the preset sealing time duration, delivery of energy ceases, thus concluding the sealing cycle.
4D. If, at any time during any pulse, the tissue impedance value exceeds the impedance threshold for energy-cutback threshold value, the level of energy being delivered is cutback. In some embodiments, the energy is cutback immediately; in other embodiments the energy is cut back following the passage of a preset energy cutback time. Following the energy cutback, the sealing cycle proceeds until either the impedance threshold for energy cutback is exceeded again (in which case, energy is cutback again), or until the preset sealing duration time is achieved, as in 4C, whereupon the delivery of energy ceases.
FIGS. 5-8 provide examples and demonstrations of aspects of the electrosurgical tissue sealing method provided herein. FIG. 5 is a timing diagram showing an example of an impedance-mediated power delivery ramp as it occurs in a series of four pulses (40, 42, 44, and 46), each of which is preset to be 3 seconds in duration. As seen in Table 1, the length of the pulse intervals may be preset to vary from this 3-second duration within a range of about 0.5 sec to about 10 sec. In this present example of the method, the pulses (or pulse intervals) are all equivalent in duration. In alternative embodiments of the method, the pulse duration or intervals may also vary in length from one to another, either by a preset schedule or in response to a comparison of sensed impedance values against impedance threshold values during a sealing cycle. When pulses are of a varying duration during a sealing cycle, they may be preset to either increase or decrease in length through the cycle, or they may increase or decrease in any preset pattern. When pulse length varies in response to sensed impedance values, the length may increase or decrease in any pattern.
In the example provided by FIG. 5, the total amount of energy being delivered is decreasing with each successive pulse. The slope of the first ramp interval 40 includes a first, steep portion, a shallow middle portion, and a substantially flat third portion. Upon the conclusion of the pulse, the energy is reduced and the next ramp is initiated. In this embodiment of the method, the slope of each ramp is adjusted in real time, in response to the rate of change of tissue impedance during the preceding pulse. The slope of the second ramp 42 includes an initial portion that is shallower than that of first ramp 40; and the slope of the third ramp 44 is shallower than the initial portion of ramp 42 preceding it; and the initial slope of the fourth ramp 46 is even more shallow. The area under each ramp indicates the total energy supplied to the tissue during the ramp. Thus, in this example, a decreasing amount of energy is applied during each successive pulse. In other embodiments of the system and method, the ramped RF values and the slope between them may be varied independently in response to sensed impedance values. This pattern of a gradual decrease in energy being delivered in each pulse, following by a leveling off energy delivery is typical of an electrosurgical sealing cycle in which the sensed impedance is falling below the impedance threshold for the RF setpoint.
FIG. 6 is another timing diagram showing an example of an impedance-mediated energy delivery ramp as it occurs in a series of three pulses (50, 52, and 54) being operated according to an aspect of the method. In FIG. 5, an initial energy ramp 50 is supplied to the tissue. In this case, in response to tissue impedance readings and comparison to impedance threshold values, an increase in pulse profile subsequent to the initial pulse is provided. Once the desired impedance is reached, the energy supplied to the tissue at pulses 52 and 54 is maintained at a desired level for a predetermined interval of time. This pattern of a gradual increase in energy being delivered in each pulse, following by a leveling off energy delivery is typical of an electrosurgical sealing cycle in which the sensed impedance is exceeding the impedance threshold for the RF setpoint.
FIGS. 7A and 7B are companion figures that show aspects of events underlying an electrosurgical sealing procedure that occurs in a series of four 3-second pulses, as provided by an aspect of the method. FIG. 7A shows the profile of RF energy pulses delivered during the procedure, while FIG. 7B focuses on the coincident tissue impedance profile. The length of each pulse is labeled as the RF Pulse Duration and the maximum number of pulses allowed for each seal is labeled as the Max RF Pulse Count. The following events occur during this electrosurgical tissue sealing procedure example:
1. The first RF pulse for a tissue sealing procedure starts at a power level labeled as the RF Setpoint Start Value (FIG. 7A).
2. The RF power level is increased from the RF Setpoint Start Value at a preset RF Ramping Rate until the power level reaches the upper level labeled as the RF Setpoint End Value. The RF power level remains at this value until the end of the 3-second pulse time is reached (FIG. 7A).
3. At the end of each pulse, the sensed tissue impedance value is determined and recorded as the RF Pulse End Impedance (FIG. 7B), and the power level is then set to zero (FIG. 7A).
4. For all pulses subsequent to the first, the following evaluations are made (FIGS. 7A and 7B):
a. If the RF Pulse End Impedance is less than the Threshold for RF Setpoint, the RF power delivered is ramped at a rate identical to that of the first pulse.
b. If the RF Pulse End Impedance is greater than the Threshold for RF Setpoint, the RF power delivered is stepped directly to the RF Setpoint End Value.
FIG. 7B shows the course of tissue impedance events that relate to controlling energy delivery and terminating the electrosurgical procedure. The sealing cycle is terminated when the tissue impedance reaches a predetermined Impedance Threshold for Cumulative Time. (A detected fault or error condition can also terminate a sealing cycle.) Stopping the sealing procedure in accordance with the cumulative sealing endpoint duration value occurs as follows:
1. Tissue impedance is determined using the signals from the RF monitoring hardware circuits.
2. When the calculated tissue impedance exceeds the Impedance Threshold for Cumulative Time (in this example, 250 Ohms), a cumulating endpoint timer is started. When the calculated tissue impedance falls below the Impedance Threshold for Cumulative Time (e.g., when a pulse completes), the endpoint timer is halted. Thus, the timer records only the total time that tissue impedance is greater than the Impedance Threshold for Cumulative Time.
3. When the timer accumulates a preset amount of time, labeled as the Seal Endpoint Time, the RF delivery is halted, the system user is notified of the completed seal and the system is placed in the ready state.
FIG. 8 provides an example of an electrosurgical tissue sealing procedure that is modified in order to accommodate a low amount of tissue within the target locale, between the jaws of electrosurgical forceps. A relatively low amount of tissue may occur when the tissue is particularly thin (for example, 0.5 mm thickness or less) or when portions of the electrode are not in contact with any tissue. As described above, a low tissue circumstance typically creates a high impedance level. The events shown in FIG. 8 occur during a single 3-second pulse. The following steps illustrate how aspects of the method intervene to correct for low tissue presence.
1. Tissue impedance is calculated using the signals from the RF monitoring hardware circuits.
2. When the sensed tissue impedance exceeds the Impedance Threshold for Energy Cutback, for a time duration labeled as the Impedance Cutback Time (in this example, 0.1 sec), the RF delivery is reduced by decreasing the RF Voltage being delivered (see Table 1). The cutback in energy delivery is reflected in the immediate drop in sensed tissue impedance. If the tissue impedance were to exceed the Impedance Threshold for Energy Cutback a second time, the RF Voltage would be reduced again.
3. When sensed tissue impedance exceeds an Impedance Threshold for Cumulative Time (in this example, 250 ohms), an Endpoint Timer is activated. On completion of a predetermined amount of time, the Seal Endpoint Time (in this example, 1.5 seconds), as recorded by the Endpoint Timer, the electrosurgical procedure or sealing cycle is terminated.
Unless defined otherwise, all technical terms used herein have the same meanings as commonly understood by one of ordinary skill in the art of electrosurgery. Specific methods, devices, and materials are described in this application, but any methods and materials similar or equivalent to those described herein can be used in the practice of the present invention. While embodiments of the invention have been described in some detail and by way of illustrations, such illustration is for purposes of clarity of understanding only, and is not intended to be limiting. Various terms have been used in the description to convey an understanding of the invention; it will be understood that the meaning of these various terms extends to common linguistic or grammatical variations or forms thereof. It will also be understood that when terminology referring to devices or equipment, that these terms or names are provided as contemporary examples, and the invention is not limited by such literal scope. Terminology that is introduced at a later date that may be reasonably understood as a derivative of a contemporary term or designating of a hierarchal subset embraced by a contemporary term will be understood as having been described by the now contemporary terminology. Further, while some theoretical considerations have been advanced in furtherance of providing an understanding of the dynamics of tissue response to absorbing radiofrequency energy, consequences regarding tissue impedance, and exploiting these dynamics toward optimizing control of an electrosurgical system and method, the claims to the invention are not bound by such theory. Moreover, any one or more features of any embodiment of the invention can be combined with any one or more other features of any other embodiment of the invention, without departing from the scope of the invention. Still further, it should be understood that the invention is not limited to the embodiments that have been set forth for purposes of exemplification, but is to be defined only by a fair reading of claims appended to the patent application, including the full range of equivalency to which each element thereof is entitled.
US3356408 7 juil. 1966 5 déc. 1967 Sturtz Herbert D Camper anchoring device
US3527224 5 sept. 1967 8 sept. 1970 American Cyanamid Co Method of surgically bonding tissue together
US3709215 28 déc. 1970 9 janv. 1973 Richmond S Anterior vaginal retractor for vaginal surgery
US3742955 29 sept. 1970 3 juil. 1973 Fmc Corp Fibrous collagen derived product having hemostatic and wound binding properties
US3845771 24 avr. 1973 5 nov. 1974 Vise W Electrosurgical glove
US4018230 2 avr. 1975 19 avr. 1977 Kazuo Ochiai Cervical dilator
US4072153 3 mars 1976 7 févr. 1978 Swartz William H Post hysterectomy fluid drainage tube
US4867649 15 déc. 1986 19 sept. 1989 Hitachi, Ltd. Refrigerating system
US4972846 31 janv. 1989 27 nov. 1990 W. L. Gore & Associates, Inc. Patch electrodes for use with defibrillators
US4976717 24 avr. 1989 11 déc. 1990 Boyle Gary C Uterine retractor for an abdominal hysterectomy and method of its use
US4998527 26 mars 1990 12 mars 1991 Percutaneous Technologies Inc. Endoscopic abdominal, urological, and gynecological tissue removing device
US5037379 22 juin 1990 6 août 1991 Vance Products Incorporated Surgical tissue bag and method for percutaneously debulking tissue
US5041101 5 juin 1989 20 août 1991 Helix Medical, Inc. Hysterectomy drain appliance
US5059782 11 juil. 1990 22 oct. 1991 Astex Co., Ltd. Multi-function detection circuit for a photoelectric switch using an integrated circuit with reduced interconnections
US5108408 20 avr. 1990 28 avr. 1992 Lally James J Uterine-ring hysterectomy clamp
US5178618 16 janv. 1991 12 janv. 1993 Brigham And Womens Hospital Method and device for recanalization of a body passageway
US5234425 24 nov. 1992 10 août 1993 Thomas J. Fogarty Variable diameter sheath method and apparatus for use in body passages
US5250074 14 juil. 1992 5 oct. 1993 Wilk Peter J Surgical instrument assembly and associated technique
US5354336 15 mars 1993 11 oct. 1994 Autogenesis Technologies, Inc. Method for bonding soft tissue with collagen-based adhesives and sealants
US5377415 10 déc. 1993 3 janv. 1995 Gibson; John Sheet material punch
US5397320 3 mars 1994 14 mars 1995 Essig; Mitchell N. Dissecting surgical device and associated method
US5423809 * 30 août 1993 13 juin 1995 Valleylab Inc. Electrosurgical control for a trocar
US5447513 27 août 1993 5 sept. 1995 Ethicon, Inc. Endoscopic ligation and division instrument
US5449355 24 nov. 1993 12 sept. 1995 Valleylab Inc. Retrograde tissue splitter and method
US5520698 19 oct. 1994 28 mai 1996 Blairden Precision Instruments, Inc. Simplified total laparoscopic hysterectomy method employing colpotomy incisions
US5562700 9 mai 1995 8 oct. 1996 Ethicon Endo-Surgery, Inc. Cable-actuated jaw assembly for surgical instruments
US5562702 9 mai 1995 8 oct. 1996 Ethicon Endo-Surgery, Inc. Cable-actuated jaw assembly for surgical instruments
US5603700 27 déc. 1993 18 févr. 1997 Daneshvar; Yousef Suction and injection system
US5653692 7 sept. 1995 5 août 1997 Innerdyne Medical, Inc. Method and system for direct heating of fluid solution in a hollow body organ
US5675184 17 janv. 1996 7 oct. 1997 Mitsubishi Denki Kabushiki Kaisha Integrated circuit device
US5715832 28 févr. 1995 10 févr. 1998 Boston Scientific Corporation Deflectable biopsy catheter
US5728143 14 févr. 1996 17 mars 1998 Rita Medical Systems, Inc. Multiple antenna ablation apparatus and method
US5735289 8 août 1996 7 avr. 1998 Pfeffer; Herbert G. Method and apparatus for organic specimen retrieval
US5746750 5 févr. 1997 5 mai 1998 Richard Wolf Gmbh Medical instrument for manipulation of the uterus
US5788662 22 oct. 1996 4 août 1998 Plasmaseal Llc Methods for making concentrated plasma and/or tissue sealant
US5797906 28 avr. 1995 25 août 1998 Valleylab Inc Retrograde tissue splitter and method
US5817092 5 nov. 1996 6 oct. 1998 Radio Therapeutics Corporation Apparatus, system and method for delivering radio frequency energy to a treatment site
US5833689 4 avr. 1996 10 nov. 1998 Snj Company, Inc. Versatile electrosurgical instrument capable of multiple surgical functions
US5840077 17 oct. 1995 24 nov. 1998 Blairden Precision Instruments, Inc. Uterine manipulating assembly for laparoscopic hysterectomy
US5855576 12 déc. 1996 5 janv. 1999 Board Of Regents Of University Of Nebraska Method for volumetric tissue ablation
US5893835 10 oct. 1997 13 avr. 1999 Ethicon Endo-Surgery, Inc. Ultrasonic clamp coagulator apparatus having dual rotational positioning
US5893874 7 févr. 1997 13 avr. 1999 Smith & Nephew, Inc. Surgical instrument
US5931835 13 juin 1997 3 août 1999 C. R. Bard Radio frequency energy delivery system for multipolar electrode catheters
US5979453 6 nov. 1996 9 nov. 1999 Femrx, Inc. Needle myolysis system for uterine fibriods
US6039735 3 oct. 1997 21 mars 2000 Megadyne Medical Products, Inc. Electric field concentrated electrosurgical electrode
US6050993 27 juil. 1998 18 avr. 2000 Quantum Therapeutics Corp. Medical device and methods for treating hemorrhoids
US6050995 24 sept. 1998 18 avr. 2000 Scimed Lifesystems, Inc. Polypectomy snare with multiple bipolar electrodes
US6059766 27 févr. 1998 9 mai 2000 Micro Therapeutics, Inc. Gynecologic embolotherapy methods
US6068626 10 août 1999 30 mai 2000 Adiana, Inc. Method and apparatus for tubal occlusion
US6071281 5 mai 1998 6 juin 2000 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same
US6142992 * 10 avr. 1998 7 nov. 2000 Arthrocare Corporation Power supply for limiting power in electrosurgery
US6152932 12 févr. 1997 28 nov. 2000 Safe Conduct Ab Device for extraction of tissue
US6179832 21 août 1998 30 janv. 2001 Vnus Medical Technologies, Inc. Expandable catheter having two sets of electrodes
US6212426 1 nov. 1999 3 avr. 2001 Scimed Life Systems, Inc. Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6217894 4 janv. 2000 17 avr. 2001 Focal, Inc. Compliant tissue sealants
US6228084 6 avr. 1999 8 mai 2001 Kirwan Surgical Products, Inc. Electro-surgical forceps having recessed irrigation channel
US6245069 26 mai 1999 12 juin 2001 Karl Storz Gmbh & Co. Kg Cutting loop electrode for high-frequency instrument
US6254601 8 déc. 1998 3 juil. 2001 Hysterx, Inc. Methods for occlusion of the uterine arteries
US6283963 7 oct. 1998 4 sept. 2001 Ethicon, Inc. Bipolar electrosurgical scissors for fine or delicate surgical dissection
US6293946 27 août 1999 25 sept. 2001 Link Technology, Inc. Non-stick electrosurgical forceps
US6312430 20 sept. 1999 6 nov. 2001 Endoscopic Concepts, Inc. Bipolar electrosurgical end effectors
US6322494 18 mars 1999 27 nov. 2001 Gyrus Medical Limited Endoscope
US6371956 17 août 1999 16 avr. 2002 Endoscopic Concepts, Inc. Monopolar electrosurgical end effectors
US6485486 4 août 1998 26 nov. 2002 Trustees Of Dartmouth College System and methods for fallopian tube occlusion
US6491690 15 juil. 1998 10 déc. 2002 Gyrus Medical Limited Electrosurgical instrument
US6494881 30 sept. 1997 17 déc. 2002 Scimed Life Systems, Inc. Apparatus and method for electrode-surgical tissue removal having a selectively insulated electrode
US6517530 31 oct. 1997 11 févr. 2003 Leiv Eiriksson Nyfotek As Probe device
US6520185 1 sept. 1999 18 févr. 2003 Ntero Surgical, Inc. Systems and methods for reducing post-surgical complications
US6546933 29 juin 2000 15 avr. 2003 Inbae Yoon Occlusion apparatus and method for necrotizing anatomical tissue structures
US6565560 15 juil. 1998 20 mai 2003 Gyrus Medical Limited Electrosurgical instrument
US6610074 9 févr. 2001 26 août 2003 Albert N. Santilli Aorta cross clamp assembly
US6616654 27 juil. 2001 9 sept. 2003 Starion Instruments Corporation Polypectomy device and method
US6616659 27 juil. 2001 9 sept. 2003 Starion Instruments Corporation Polypectomy device and method
US6623482 28 sept. 2001 23 sept. 2003 Ethicon, Inc. Electrosurgical instrument with minimally invasive jaws
US6648839 8 mai 2002 18 nov. 2003 Misonix, Incorporated Ultrasonic medical treatment device for RF cauterization and related method
US6666859 9 sept. 2002 23 déc. 2003 Megadyne Medical Products, Inc. Self-limiting electrosurgical return electrode
US6673085 18 mai 2001 6 janv. 2004 St. Jude Medical Atg, Inc. Anastomosis techniques
US6682526 17 nov. 2000 27 janv. 2004 Vnus Medical Technologies, Inc. Expandable catheter having two sets of electrodes, and method of use
US6726682 12 févr. 2002 27 avr. 2004 Adiana, Inc. Method and apparatus for tubal occlusion
US6736814 28 févr. 2002 18 mai 2004 Misonix, Incorporated Ultrasonic medical treatment device for bipolar RF cauterization and related method
US6746488 19 mars 2002 8 juin 2004 Biomet, Inc. Method and apparatus for hindering osteolysis in porous implants
US6752803 6 juil. 2001 22 juin 2004 Vnus Medical Technologies, Inc. Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression
US6796981 * 11 févr. 2002 28 sept. 2004 Sherwood Services Ag Vessel sealing system
US6852108 14 mai 2002 8 févr. 2005 Spiration, Inc. Apparatus and method for resecting and removing selected body tissue from a site inside a patient
US6889089 11 avr. 2001 3 mai 2005 Scimed Life Systems, Inc. Apparatus and method for treating tumors near the surface of an organ
US6896672 1 mai 2000 24 mai 2005 Arthrocare Corporation Methods for electrosurgical incisions on external skin surfaces
US6902536 17 nov. 2003 7 juin 2005 Milsonix Incorporated Ultrasonic medical treatment device for RF cauterization and related method
US6918909 10 avr. 2003 19 juil. 2005 Olympus Corporation Resectoscope apparatus
US6923803 7 janv. 2002 2 août 2005 Gyrus Medical Limited Electrosurgical system and method
US6929642 23 oct. 2002 16 août 2005 Ethicon, Inc. RF device for treating the uterus
US6936048 16 janv. 2003 30 août 2005 Charlotte-Mecklenburg Hospital Authority Echogenic needle for transvaginal ultrasound directed reduction of uterine fibroids and an associated method
US7090637 23 mai 2003 15 août 2006 Novare Surgical Systems, Inc. Articulating mechanism for remote manipulation of a surgical or diagnostic tool
US7090685 25 mars 2003 15 août 2006 Ethicon Endo-Surgery, Inc. Surgical tool having a distal ratchet mechanism
US7094235 13 janv. 2004 22 août 2006 Medtronic, Inc. Method and apparatus for tissue ablation
US7166102 9 mai 2002 23 janv. 2007 Megadyne Medical Products, Inc. Self-limiting electrosurgical return electrode
US7291143 5 avr. 2006 6 nov. 2007 Boston Scientific Scimed, Inc. Clamp based low temperature lesion formation apparatus, systems and methods
US7303557 * 27 déc. 2004 4 déc. 2007 Sherwood Services Ag Vessel sealing system
US7410483 24 nov. 2004 12 août 2008 Novare Surgical Systems, Inc. Hand-actuated device for remote manipulation of a grasping tool
US7588566 30 avr. 2007 15 sept. 2009 The Trustees Of Columbia University In The City Of New York Electrothermal instrument for sealing and joining or cutting tissue
US8147485 * 23 févr. 2009 3 avr. 2012 Covidien Ag System and method for tissue sealing
US20010029367 31 janv. 2001 11 oct. 2001 Megadyne Medical Products, Inc. Pressure sore pad having self-limiting electrosurgical return electrode properties and optional heating/cooling capabilities
US20020062123 5 sept. 2001 23 mai 2002 Mcclurken Michael E. Fluid-assisted medical devices, fluid delivery systems and controllers for such devices, and methods
US20020062136 29 août 2001 23 mai 2002 Hillstead Richard A. Medical instrument
US20020107514 9 nov. 2001 8 août 2002 Hooven Michael D. Transmural ablation device with parallel jaws
US20020124853 20 juil. 2001 12 sept. 2002 Fred Burbank Methods for minimally-invasive, non-permanent occlusion of a uterine artery
US20020128643 28 déc. 2000 12 sept. 2002 Simpson John A. Ablation system and method having multiple-sensor electrodes to assist in assessment of electrode and sensor position and adjustment of energy levels
US20020151882 31 mai 2002 17 oct. 2002 Alexei Marko Device for thermal ablation of a cavity
US20020177848 24 mai 2001 28 nov. 2002 Csaba Truckai Electrosurgical working end for sealing tissue
US20020183734 26 févr. 2002 5 déc. 2002 Bommannan D. Bommi System and method for reducing post-surgical complications
US20020183738 14 mars 2002 5 déc. 2002 Chee U. Hiram Method and apparatus for treatment of atrial fibrillation
US20030004510 * 11 févr. 2002 2 janv. 2003 Robert Wham Vessel sealing system
US20030015855 3 juil. 2002 23 janv. 2003 Mccoy Richard W. Fifth wheel hitch assembly with improved jaw mechanism
US20030144653 25 janv. 2002 31 juil. 2003 Medtronic, Inc. System and method of performing an electrosurgical procedure
US20030158547 19 févr. 2002 21 août 2003 Phan Huy D. Apparatus for converting a clamp into an electrophysiology device
US20030158551 * 19 févr. 2002 21 août 2003 Paton Boris E. System and method for control of tissue welding
US20030199869 30 oct. 2002 23 oct. 2003 Johnson Kristin D. Vessel sealing instrument
US20030216726 20 mars 2003 20 nov. 2003 Arthrocare Corporation Systems for epidermal tissue ablation
US20030236549 21 janv. 2003 25 déc. 2003 Frank Bonadio Surgical instrument
US20040006339 2 juil. 2003 8 janv. 2004 Arthrocare Corporation Method for treating obstructive sleep disorder includes removing tissue from the base of tongue
US20040068274 2 oct. 2002 8 avr. 2004 Hooven Michael D. Articulated clamping member
US20040097919 8 juil. 2003 20 mai 2004 Ethicon, Inc. Surgical device for clamping, ligating, and severing tissue
US20040106917 8 août 2003 3 juin 2004 Ormsby Theodore C. Radio-frequency based catheter system and method for ablating biological tissues
US20040167508 * 21 janv. 2004 26 août 2004 Robert Wham Vessel sealing system
US20040193148 * 24 juil. 2003 30 sept. 2004 Wham Robert H. Vessel sealing system
US20040199226 22 avr. 2004 7 oct. 2004 Shadduck John H. Thermotherapy device with superlattice cooling
US20050010212 9 août 2004 13 janv. 2005 Tissuelink Medical. Inc. Fluid-assisted medical devices, systems and methods
US20050015085 30 mars 2004 20 janv. 2005 Tissuelink Medical, Inc. Fluid-assisted medical devices, systems and methods
US20050019654 26 juin 2003 27 janv. 2005 Akira Kishida Battery provided with terminals
US20050021024 18 août 2004 27 janv. 2005 Hooven Michael D. Transmural ablation device with temperature sensor
US20050021026 28 avr. 2004 27 janv. 2005 Ali Baily Method of fusing biomaterials with radiofrequency energy
US20050033276 21 juin 2004 10 févr. 2005 Olympus Corporation Blood vessel detection device
US20050033277 13 août 2004 10 févr. 2005 Clague Cynthia T. Electrosurgical methods and apparatus for making precise incisions in body vessels
US20050033282 27 août 2004 10 févr. 2005 Hooven Michael D. Transmural ablation device with parallel electrodes
US20050070895 30 sept. 2003 31 mars 2005 Thomas Ryan Electrosurgical instrument and method for transecting an organ
US20050070978 27 oct. 2004 31 mars 2005 Curon Medical, Inc. Systems and methods for monitoring and controlling use of medical devices
US20050090819 25 févr. 2004 28 avr. 2005 Gyrus Medical Limited Electrosurgical system and method
US20050096694 12 avr. 2004 5 mai 2005 Woojin Lee Surgical instrument
US20050101951 * 27 déc. 2004 12 mai 2005 Robert Wham Vessel sealing system
US20050107781 18 nov. 2004 19 mai 2005 Isaac Ostrovsky System and method for tissue ablation
US20050107784 22 juin 2004 19 mai 2005 Moses Michael C. Open vessel sealing instrument with cutting mechanism and distal lockout
US20050113817 21 nov. 2003 26 mai 2005 Isaacson James D. Tuned return electrode with matching inductor
US20050113820 8 déc. 2004 26 mai 2005 Gyrus Medical Limited Electrosurgical generator and system
US20050119654 2 déc. 2003 2 juin 2005 Swanson David K. Clamp based methods and apparatus for forming lesions in tissue and confirming whether a therapeutic lesion has been formed
US20050131390 25 avr. 2003 16 juin 2005 Russell Heinrich Surgical instruments including mems devices
US20050137591 1 févr. 2005 23 juin 2005 Barry Robert L. Apparatus and method for resecting and removing selected body tissue from a site inside a patient
US20050149073 19 mai 2004 7 juil. 2005 Arani Djavad T. Mechanisms and methods used in the anastomosis of biological conduits
US20050171530 18 févr. 2005 4 août 2005 Hooven Michael D. Transmural ablation device
US20050187561 24 févr. 2005 25 août 2005 Femasys, Inc. Methods and devices for conduit occlusion
US20050192568 29 avr. 2005 1 sept. 2005 Surgrx, Inc. Electrosurgical jaw structure for controlled energy delivery
US20050192633 21 janv. 2005 1 sept. 2005 Montpetit Karen P. Tissue fastening and cutting tool, and methods
US20050203500 29 sept. 2004 15 sept. 2005 Usgi Medical Inc. Apparatus and methods for mapping out endoluminal gastrointestinal surgery
US20050226682 2 juin 2005 13 oct. 2005 David Chersky Method and apparatus for improved stiffness in the linkage assembly of a flexible arm
US20050256522 12 mai 2004 17 nov. 2005 Medtronic, Inc. Device and method for determining tissue thickness and creating cardiac ablation lesions
US20050256524 12 mai 2005 17 nov. 2005 Long Gary L RF ablation device and method of use
US20050259035 19 mai 2005 24 nov. 2005 Olympus Corporation User support apparatus
US20050261676 25 août 2004 24 nov. 2005 Gyrus Medical Limited Surgical instrument
US20060025765 29 juil. 2005 2 févr. 2006 Jaime Landman Electrosurgical systems and methods
US20060025812 31 mars 2005 2 févr. 2006 Ethicon Endo-Surgery, Inc. Surgical instrument incorporating an electrically actuated pivoting articulation mechanism
US20060041254 21 janv. 2005 23 févr. 2006 Medtronic, Inc. Electrosurgical hemostat
US20060064084 20 sept. 2004 23 mars 2006 Dieter Haemmerich Electrode array for tissue ablation
US20060079872 3 oct. 2005 13 avr. 2006 Eggleston Jeffrey L Devices for detecting heating under a patient return electrode
US20060142751 21 févr. 2006 29 juin 2006 Treat Michael R Electrothermal instrument for sealing and joining or cutting tissue
US20060167451 26 janv. 2005 27 juil. 2006 Ethicon Endo-Surgery, Inc. Medical instrument including an end effector having a medical-treatment electrode
US20060190029 19 juil. 2005 24 août 2006 Wales Kenneth S Surgical instrument with laterally moved shaft actuator coupled to pivoting articulation joint
US20060229665 7 avr. 2005 12 oct. 2006 Ethicon Endo-Surgery, Inc. Surgical instrument with articulating shaft with single pivot closure and double pivot frame ground
US20060253117 9 mars 2006 9 nov. 2006 Arthrocare Corporation Systems and methods for electrosurgical treatment of obstructive sleep disorders
US20060258954 13 mai 2005 16 nov. 2006 Tyler Timberlake Biopsy forceps assemblies
US20060259034 10 mai 2006 16 nov. 2006 Joseph Eder Apparatus for Tissue Cauterization
US20060259035 10 mai 2006 16 nov. 2006 Camran Nezhat Method and Apparatus for Performing a Surgical Procedure
US20060271037 25 mai 2005 30 nov. 2006 Forcept, Inc. Assisted systems and methods for performing transvaginal hysterectomies
US20060271041 10 mai 2006 30 nov. 2006 Joseph Eder Method for Tissue Cauterization
US20060271042 26 mai 2005 30 nov. 2006 Gyrus Medical, Inc. Cutting and coagulating electrosurgical forceps having cam controlled jaw closure
US20060293655 28 juin 2005 28 déc. 2006 Sherwood Services Ag Electrode with rotatably deployable sheath
US20070005053 30 juin 2005 4 janv. 2007 Dando Jeremy D Ablation catheter with contoured openings in insulated electrodes
US20070005061 30 juin 2005 4 janv. 2007 Forcept, Inc. Transvaginal uterine artery occlusion
US20070055231 31 août 2006 8 mars 2007 Dycus Sean T Vessel sealer and divider
US20070128174 21 sept. 2006 7 juin 2007 Kleinsek Donald A Methods and compositions for organ and tissue functionality
US20070129726 6 févr. 2007 7 juin 2007 Eder Joseph C Electrocautery method and apparatus
US20070179497 6 avr. 2007 2 août 2007 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US20070185482 6 févr. 2007 9 août 2007 Eder Joseph C Electrocautery method and apparatus
US20070208330 30 avr. 2007 6 sept. 2007 Treat Michael R Electrothermal Instrument For Sealing And Joining Or Cutting Tissue
US20070244538 22 juin 2007 18 oct. 2007 Eder Joseph C Transvaginal Uterine Artery Occlusion
US20070250113 16 avr. 2007 25 oct. 2007 Hegeman David E Tool with articulation lock
US20070265613 3 avr. 2007 15 nov. 2007 Edelstein Peter Seth Method and apparatus for sealing tissue
US20070282318 16 mai 2007 6 déc. 2007 Spooner Gregory J Subcutaneous thermolipolysis using radiofrequency energy
US20070299439 26 mars 2007 27 déc. 2007 Gyrus Medical, Inc. Bipolar cutting and coagulating forceps
US20080015562 20 juil. 2007 17 janv. 2008 Medtronic, Inc. Transmural ablation systems and methods
US20080114351 31 oct. 2006 15 mai 2008 Takashi Irisawa High-frequency operation apparatus and method for controlling high-frequency output based on change with time of electrical parameter
US20080172052 2 mai 2007 17 juil. 2008 Joseph Eder Surgical Tool
US20080188844 1 févr. 2007 7 août 2008 Mcgreevy Francis T Apparatus and method for rapid reliable electrothermal tissue fusion and simultaneous cutting
US20080228179 4 avr. 2008 18 sept. 2008 Joseph Charles Eder Electrocautery method and apparatus
US20080275446 17 avr. 2008 6 nov. 2008 Messerly Jeffrey D Two-piece jaw for bipolar ablation device
US20090138006 27 nov. 2008 28 mai 2009 Bales Thomas O Cordless power-assisted medical cauterization and cutting device
US20090171354 13 mars 2009 2 juil. 2009 Derek Dee Deville Cordless Medical Cauterization and Cutting Device
US20090182323 24 mars 2009 16 juil. 2009 Aragon Surgical, Inc. Electrocautery method and apparatus
US20090198272 6 févr. 2008 6 août 2009 Lawrence Kerver Method and apparatus for articulating the wrist of a laparoscopic grasping instrument
US20090209953 16 janv. 2009 20 août 2009 Tyco Healthcare Group Lp Multi-Layer Return Electrode
US20090234347 29 mai 2009 17 sept. 2009 The Trustees Of Columbia University In The City Of New York Electrothermal instrument for sealing and joining or cutting tissue
US20090240245 13 mars 2009 24 sept. 2009 Derek Dee Deville Method for Powering a Surgical Instrument
US20100076427 25 sept. 2008 25 mars 2010 Tyco Healthcare Group Lp Seal and Separate Algorithm
US20100094282 15 oct. 2008 15 avr. 2010 Olympus Medical Systems Corp. Electrosurgical apparatus and method of controlling electrosurgical apparatus
US20100280508 27 août 2009 4 nov. 2010 Joseph Charles Eder Method and Apparatus for RF Anastomosis
US20100298823 6 déc. 2006 25 nov. 2010 Hong Cao Assessment of electrode coupling for tissue ablation
US20110202058 28 avr. 2011 18 août 2011 Joseph Eder Apparatus for Tissue Cauterization
CA2061215A1 14 févr. 1992 16 août 1992 Ingemar H. Lundquist Torquable catheter and method
CN1250360C 9 mai 2000 12 avr. 2006 邓特斯普里国际公司 Shell mold binder composition and method
CN1882289B 16 août 2004 18 mai 2011 玛格戴恩医疗产品公司 Tuned return electrode with matching inductor
EP0440385A2 25 janv. 1991 7 août 1991 Everest Medical Corporation Electrosurgical instrument for conducting endoscopic retrograde sphicterotomy
EP0487269A1 15 nov. 1991 27 mai 1992 Everest Medical Corporation Biopsy device with bipolar coagulation capability
EP0502268A1 4 mars 1991 9 sept. 1992 Everest Medical Corporation Electrosurgical instrument having needle cutting electrode and spot-coagulation electrode
EP0536998B1 8 oct. 1992 4 sept. 1996 Ethicon Inc. Monopolar electrosurgical device with irrigation and suction controls for endoscopic surgery
EP0562195A1 17 déc. 1992 29 sept. 1993 Everest Medical Corporation Monopolar polypectomy snare with coagulation electrode
EP0640315B1 21 juil. 1994 30 déc. 1998 Ethicon Inc. Electrosurgical stapling device
EP0658333A1 16 déc. 1994 21 juin 1995 United States Surgical Corporation Monopolar electrosurgical instruments
EP0717960B1 21 déc. 1995 26 févr. 2003 Ethicon Endo-Surgery, Inc. Electrosurgical hemostatic device
EP0737446B1 11 avr. 1996 11 déc. 2002 Ethicon Endo-Surgery, Inc. Electrosurgical hemostatic device
EP0742696B1 31 janv. 1995 5 nov. 2003 Medical Corporation Apple Electrosurgical excisor for uterine cervix
EP0771176B2 20 juin 1996 4 janv. 2006 Gyrus Medical Limited An electrosurgical instrument
EP0794735B1 29 nov. 1995 21 juil. 2004 Ethicon Endo-Surgery, Inc. Alternative current pathways for bipolar surgical cutting tool
EP0833593B1 20 juin 1996 28 févr. 2001 Gyrus Medical Limited An electrosurgical instrument
EP0869742B1 11 déc. 1996 21 mai 2003 Cyrus Medical Limited An electrosurgical instrument and an electrosurgical electrode assembly
EP0873089B1 9 janv. 1997 22 oct. 2003 Gyrus Medical Limited Electrosurgical instrument
EP0913126B1 26 août 1998 13 oct. 2004 Ethicon, Inc. Combined bipolar scissor and grasper
EP0927543B1 7 oct. 1998 20 avr. 2005 Ethicon, Inc. Bipolar electrosurgical scissors for fine or delicate surgical dissection
EP0956827B1 27 avr. 1999 13 oct. 2004 Erbe Elektromedizin GmbH. Electrosurgical apparatus
EP0959784B1 9 janv. 1997 21 avr. 2004 Gyrus Medical Limited An electrosurgical instrument
EP0959786B1 17 juin 1997 22 sept. 2004 Gyrus Medical Limited Electrosurgical instrument for underwater treatments
EP1004277B1 25 nov. 1999 21 juil. 2004 Medsys S.A. An electrosurgical loop and instrument for laparoscopic surgery
EP1039862B1 14 déc. 1998 21 mai 2008 ArthroCare Corporation Systems for electrosurgical treatment of the head and neck
EP1041933B1 18 nov. 1998 31 mars 2004 ArthroCare Corporation Systems for electrosurgical treatment of the skin
EP1064886B1 28 juin 2000 16 août 2006 Ethicon Endo-Surgery Multiple balloon electrosurgical catheter
EP1254637B1 21 déc. 1995 8 août 2007 Ethicon Endo-Surgery Electrosurgical hemostatic device
EP1293169B1 25 sept. 1996 26 juil. 2006 Erbe Elektromedizin GmbH Argon plasma flex-endoscopy coagulator
EP1293170B1 25 sept. 1996 14 juin 2006 Erbe Elektromedizin GmbH Argon plasma flex-endoscopy coagulator
EP1330989B1 9 janv. 1997 7 déc. 2005 Gyrus Medical Limited An electrosurgical instrument
EP1344498B1 9 janv. 1997 9 nov. 2005 Gyrus Medical Limited An electrosurgical instrument
EP1518498B1 29 sept. 2004 19 déc. 2007 Ethicon Endo-Surgery, Inc. Endoscopic mucosal resection device
EP1518499B1 29 sept. 2004 13 août 2008 Ethicon Endo-Surgery, Inc. Endoscopic mucosal resection device with conductive tissue stop
EP1586281B1 6 juil. 2001 1 avr. 2009 Biosense Webster, Inc. System for detecting electrode-tissue contact
EP1621146A2 27 juil. 2005 1 févr. 2006 Ethicon Endo-Surgery, Inc. Surgical instrument incorporating an articulation locking mechanism
EP1637086B1 21 sept. 2005 1 sept. 2010 Covidien AG Articulating bipolar electrosurgical instrument
EP1645234B1 7 oct. 2005 5 mai 2010 Covidien AG Electrosurgical system employing multiple electrodes
EP1645237A1 6 oct. 2005 12 avr. 2006 Sherwood Services AG Endoscopic bipolar electrosurgical forceps
EP1767164A1 22 sept. 2005 28 mars 2007 Sherwood Services AG Electrode assembly for tissue fusion
EP1852081B1 4 mai 2007 26 août 2009 Covidien AG Vessel sealing instrument with electrical cutting mechanism
EP1862138A1 30 mai 2007 5 déc. 2007 Covidien AG Electrosurgical instrument that directs energy delivery and protects adjacent tissue
EP1958583A2 13 févr. 2008 20 août 2008 Tyco Healthcare Group, LP Vessel sealing instrument with electrical cutting mechanism
EP2065006B1 2 sept. 2005 27 mai 2015 Covidien AG Vessel sealing instrument with electrical cutting mechanism
EP2106764A2 18 nov. 1999 7 oct. 2009 Intuitive Surgical, Inc. System for performing cardiac surgery without cardioplegia
EP2110093B1 4 mai 2007 26 déc. 2012 Covidien AG Vessel sealing instrument with electrical cutting mechanism
JP2001518344A Titre non disponible
JP2003088534A Titre non disponible
JP2004049566A Titre non disponible
JP2005021703A Titre non disponible
JP2005040616A Titre non disponible
JP2005144193A Titre non disponible
JP2005512671A Titre non disponible
JP2005517498A Titre non disponible
JP2007195973A Titre non disponible
JP2008114042A Titre non disponible
JPH1170123A Titre non disponible
JPH1170124A Titre non disponible
JPH09501328A Titre non disponible
WO1992022257A1 5 juin 1992 23 déc. 1992 Hemostatix Corporation Bi-polar electrosurgical endoscopic instruments and methods of use
WO1994000060A1 18 févr. 1993 6 janv. 1994 Valleylab, Inc. An electrosurgical tubular trocar
WO1994026179A1 13 mai 1994 24 nov. 1994 Surgical Innovations, Inc. Tissue and organ extractor
WO1994026228A1 10 mai 1994 24 nov. 1994 Thapliyal And Eggers Partners Methods and apparatus for surgical cutting
WO1995002371A2 15 juil. 1994 26 janv. 1995 Aws Shakir Mustafa Salim Rectal and rectosigmoid cancer tunnelling umbrella
WO1995009576A1 9 sept. 1994 13 avr. 1995 Valleylab, Inc. Automatic control for electrosurgical generator
WO1995014436A1 12 oct. 1994 1 juin 1995 Valleylab, Inc. A retrograde high frequency tissue splitter
WO1995025471A3 23 janv. 1995 19 oct. 1995 Michael S Klicek Monopolar/bipolar electrosurgical handpiece for minimally invasive surgery
WO1996005776A1 24 août 1994 29 févr. 1996 Vesta Medical, Inc. Coagulating forceps
WO1996016605A1 29 nov. 1995 6 juin 1996 Medical Scientific, Inc. Alternative current pathways for bipolar surgical cutting tool
WO1996019152A1 4 déc. 1995 27 juin 1996 Valleylab, Inc. Adaptive monitoring for a return electrode consisting of two parts (rem)
WO1996023449A1 30 janv. 1996 8 août 1996 Boston Scientific Corporation Electro-surgical tissue removal
WO1997024073A1 11 déc. 1996 10 juil. 1997 Gyrus Medical Limited An electrosurgical instrument and an electrosurgical electrode assembly
WO1997024074A1 30 déc. 1996 10 juil. 1997 Microgyn, Inc. Apparatus and method for electrosurgery
WO1997024995A1 10 janv. 1997 17 juil. 1997 Symbiosis Corporation Endoscopic bipolar multiple sample bioptome
WO1998012999A2 24 sept. 1997 2 avr. 1998 Gynecare, Inc. System and method for applying thermal energy to tissue
WO1998043548A1 3 avr. 1998 8 oct. 1998 Sadler Cynthia D Hand-held forceps instrument
WO1998053750A1 29 mai 1998 3 déc. 1998 Sports Link, Inc., Doing Business As Link Technology Electrosurgical electrode and methods for its use
WO1999017670A1 2 juin 1998 15 avr. 1999 Megadyne Medical Products, Inc. Electric field concentrated electrosurgical electrode
WO1999023933A2 11 nov. 1998 20 mai 1999 Valleylab, Inc. Bipolar electrosurgical instrument with replaceable electrodes
WO1999051155A1 30 mars 1999 14 oct. 1999 Gyrus Medical Limited Endoscope
WO1999051158A1 30 mars 1999 14 oct. 1999 Gyrus Medical Limited An electrode assembly for an electrosurgical instrument
WO1999052459A1 1 mars 1999 21 oct. 1999 Boston Scientific Limited Electro-cautery catheter
WO1999056646A1 6 mai 1999 11 nov. 1999 Arthrocare Corporation Systems and methods for electrosurgical treatment of the digestive system
WO2000013192A1 25 août 1999 9 mars 2000 General Science And Technology Corporation Medical devices incorporating at least one element made from a plurality of twisted and drawn wires at least one of the wires being a nickel-titanium alloy wire
WO2000013193A1 25 août 1999 9 mars 2000 General Science And Technology Corp. Medical devices incorporating at least one element made from a plurality of twisted and drawn wires
WO2000051512A1 29 févr. 2000 8 sept. 2000 Sun Star Technology, Inc. Hollow hot tip catheter
WO2001012090A1 11 août 2000 22 févr. 2001 The Trustees Of Columbia University In The City Of New York Electrothermal device for coagulating, sealing and cutting tissue during surgery
WO2001035846A1 16 nov. 2000 25 mai 2001 Ganz Robert A System and method of treating abnormal tissue in the human esophagus
WO2001054602A2 31 janv. 2001 2 août 2001 Cook Ireland Ltd Electrosurgical wire knife
WO2001058372A1 14 déc. 2000 16 août 2001 Boston Scientific Limted Electro-cautery catheter
WO2001058373A1 9 févr. 2001 16 août 2001 Iotek, Inc. Surgical devices and methods for use in tissue ablation procedures
WO2001082812A1 18 avr. 2001 8 nov. 2001 Medtronic, Inc. Vibration sensitive ablation apparatus and method
WO2002024092A1 18 sept. 2001 28 mars 2002 Ntero Surgical, Inc. Systems and methods for reducing post-surgical complications
WO2002036028A1 29 oct. 2001 10 mai 2002 Gyrus Medical Limited An electrosurgical system
WO2002058542A2 24 janv. 2002 1 août 2002 Ethicon Endo-Surgery, Inc. Coagulating electrosurgical instrument with tissue dam
WO2002071926A3 13 mars 2002 23 janv. 2003 Perfect Surgical Tech Inc Method and system for heating tissue with a bipolar instrument
WO2003024348A1 26 juil. 2002 27 mars 2003 Starion Instruments Corporation Polypectomy device and method
WO2003053266A3 19 déc. 2002 4 déc. 2003 Edward W Knowlton Liquid cooled rf handpiece
WO2003088806A2 11 avr. 2003 30 oct. 2003 Vivant Medical, Inc. Localization element with energized tip
WO2003096886A3 26 févr. 2003 21 avr. 2005 Robert Lawrence Barry Apparatus and method for resecting and removing selected body tissue from a site inside a patient
WO2003103522A1 10 juin 2003 18 déc. 2003 Map Technologies Llc Methods and devices for electrosurgical electrolysis
WO2004032596A2 8 oct. 2003 22 avr. 2004 The Trustees Of Columbia University In The City Ofnew York Ringed forceps
WO2004073490A2 6 févr. 2004 2 sept. 2004 Sherwood Services Ag Vessel sealer and divider and method of manufacturing same
WO2004098383A2 29 avr. 2004 18 nov. 2004 Sherwood Services Ag Electrosurgical instrument which reduces thermal damage to adjacent tissue
WO2004103156A3 14 mai 2004 14 avr. 2005 Edward C Meagher Tissue sealer with non-conductive variable stop members and method of sealing tissue
WO2005009213A2 16 juil. 2004 3 févr. 2005 Arthrocare Corporation Rotary electrosurgical apparatus and methods thereof
WO2005030071A1 28 sept. 2004 7 avr. 2005 Emcision Limited Surgical resection device
WO2005034729A2 5 oct. 2004 21 avr. 2005 Brian Kelleher Methods and devices for soft tissue securement
WO2005079901A1 16 févr. 2005 1 sept. 2005 Boston Scientific Limited Endoscopic multi-lumen devices and related methods of use
WO2005115251A1 25 mai 2005 8 déc. 2005 Christy Cummins Surgical stapler
WO2006060431A1 30 nov. 2005 8 juin 2006 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
WO2006124518A3 11 mai 2006 22 mars 2007 Boston Scient Scimed Inc Biopsy forceps assemblies
WO2006124601A3 12 mai 2006 15 nov. 2007 Aragon Surgical Inc Method of tissue cauterization
WO2007002227A2 21 juin 2006 4 janv. 2007 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
WO2007082061A2 11 janv. 2007 19 juil. 2007 Hyperbranch Medical Technology, Inc. Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
WO2008094554A2 30 janv. 2008 7 août 2008 Conmed Corporation Apparatus for rapid reliable electrothermal tissue fusion
WO2008094564A2 30 janv. 2008 7 août 2008 Conmed Corporation Apparatus for rapid reliable electrothermal tissue fusion and simultaneous cutting
WO2008124112A1 7 avr. 2008 16 oct. 2008 Stephen Flock Inductive heating of tissues using alternating magnetic fields and uses thereof
WO2009070780A1 28 nov. 2008 4 juin 2009 Syntheon, Llc Cordless power-assisted medical cauterization and cutting device
1 "2001 Hands-On Course I-Taking it the Next Level: Advanced Laparoscopic Techniques", http://www.sages.org/01program/syllabl/ho1.html#schirme, downloaded Oct. 5, 2005, 24 pgs.
2 "2001 Nurses Program, Session 1 ", http://sages.org/01program/syllabi/nurse/nurse.html, downloaded Jan. 24, 2011, 5 pgs.
3 "A New Thermal Device for Sealing and Dividing Blood Vessel", Treat, http://www.starioninstruments.com/PDFs/Treat.pdf, downloaded Jun. 29, 2005, 2 pgs.
4 "Arthrocare Receives Clearance to Market Coblation-Based Devices for Gynecology and Laparoscopic Surgery: Clearance Includes Plasma Forceps and 21 Specific Indications", Business Wire, (Oct. 25, 2001), 524.
5 "Curon Announces the Publication of Data Supporting Durability and Effectiveness of STRETTA System-Positive One Year Follow-Up Data of U.S. Clinical Trial Published in Gastrointestinal Endoscopy", PR Newswire, NYTH10307022002, (Feb. 7, 2002).
6 "Curon Medical Announces Presentation of Positive Clinical Study Results of STRETTA Procedure for Gastroesophageal Reflux Disease (GERD)", PR Newswire, NYW07920032002, (Mar. 20, 2002).
7 "Cutting Forceps (Product Information)", GYRUS Medical, downloaded Oct. 5, 2005.
8 "Enable Medical Introduces Second Generation Bipolar Scissors", Health Industry Today, (Dec. 1998).
9 "ERBE BiClamp Brochure", http://www.erbe-med.com/erbe/media/Marketingmateriallen/85100-139-ERBE-EN-BiClamp-D024676.pdf, 6 pgs.
10 "Everest Medical Announces Introduction of 3mm Bipolar Forceps", PR Newswire, 1002MNW021, (Oct. 2, 1996).
11 "Everest Medical Discusses Patent Status: Forecasts $1 Million Revenue First Quarter: Introduces Next Generation Bipolar Scissors", (Mar. 31, 1994).
12 "Everest Medical Introduces new Quadripolar Cutting Forceps at the Global Congress for Gynecologic Endoscopy Meeting", PR Newswire, (Nov. 8, 1999), 8927.
13 "Everest Medical Reports Record First Quarter Results: Introduces Next Generation Bipolar Scissors", PR Newswire, (Apr. 19, 1994).
14 "Live Tissue Connect Technologies (Company Profile)", http://www.onemedplace.com/database/compdisplay-print.php?CompanyID=11508, (Oct. 19, 2010), 1 pg.
15 "LP Scissors (Product Information)", GYRUS Medical, downloaded Oct. 5, 2005.
16 "Lyons Dissecting Forceps (Product Information)", GYRUS Medical, downloaded Oct. 5, 2005.
17 "Medical use of Radiofrequency (RF) Energy", http://www.locateadoc.com/Site-Tools/Print.cfm, (Aug. 23, 2008), 2 pgs.
18 "Micro/Macro-Jaw Forceps (Product Information)", GYRUS Medical, downloaded Oct. 5, 2005.
19 "PKS Seal (Product Page)", http://www.gyrusacmi.com/user/display.cfm?display=product&pid=9024, 1 pg.
20 "Quadripolar Cutting Forceps Introduced by Everest Medical", Health Industry Today, vol. 63, No. 1 (Jan. 2000).
21 "Radiofrequency Energy Proven Effective Against Leading Cause of Obstructive Sleep Apnea", Business Wire, 09140175, (Sep. 14, 1998).
22 "Seal Open Forceps (Product Information)", GYRUS Medical, downloaded Oct. 5, 2005.
23 "SURGRX 510(K) Summary (# K031133)", Palo Alto, CA, (Jul. 3, 2003), 5 pgs.
24 "The Gynecare Versapoint (Product Information)", Johnson & Johnson Gateway, LLC, http://jnjgateway.com/home/jhtml?loc=USENG&page=viewContent&id=edea000100001747&parentid=fc0de00100000334, downloaded Oct. 20, 2005.
25 "The LigaSure Vessel Sealing System (Brochure)", TYCO Healthcare (Apr. 2002), 8 pgs.
26 "U.S. Patent Issued for Novare Surgical Systems Cygnet Surgical Clamp: Novare Signs Multi-Year Supply Agreement with Boston Scientific", PR Newswire, (Sep. 2, 2003).
27 "Valleylab Products-Electrosurgical Forceps: The Surgeon's Choice for Quality and Precision (Product Information)", http://www.valleylab.com/products/es/accessories/forceps-over.html, downloaded Oct. 20, 2005.
28 "Valleylab Products-Ligasure Vessel Sealing System (Product Information)", http://www.valleylab.com/product/vessel-seal/index.html, downloaded Oct. 20, 2005.
29 Abu-Rustum, NR, et al., "Transperitoneal Laparoscopic Pelvic and Para-Aortic Lymph Node Dissection Using the Argon-Beam Coagulator and Monopolar Instruments: An 8-Year Study and Description of Technique," Jun. 2003; Gynecol Oncol. 89(3): 504-13; Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA, gynbreast@mskcc.org.
30 Aoki, "Thoracoscopic Resection of the Lung with the Ultrasonic Scalpel", Ann Thorac Surg, vol. 67, No. 4 (Apr. 1999),1181-1183.
31 Australian Examination Report for Application No. 2008214068, dated Jan. 28, 2011.
32 Australian Examination Report for Application No. 2008275543, dated Nov. 9, 2010.
33 Bergamaschi, "Laparoscopic Intracorporeal Bowel Resection with Ultrasound Versus Electrosurgical Dissection", JSLS, vol. 5, No. 1 (Jan.-Mar. 2001), 17-20.
34 Briani, S. et al.; Pseudo-Bipolar Electrocoagulation With a Branched Forceps; 1967; Minerva Neurochir.; 11 (3): 306-11.
35 Cakan. A. et al.: The Histological Effect of Harmonic Scalpel and Electrocautery in Lung Resections. An Experimental Study in a Rat Model: Feb. 2004; J Cardiovasc Surq (Torino).; 45 (1): 63-5; Department of Thoracic Surgery, Ege University School of Medicine, Izmir, Turkey, alpcakan@gohip.com.
36 Canadian Application No. 2,677,300, Examination Report mailed Apr. 18, 2013.
37 Canadian Application No. 2,723,016, Office Action mailed Nov. 12, 2013.
38 Canadian Examination Report for Application No. 2,677,300, dated Aug. 25, 2011.
39 Canadian Examination Report for Application No. 2,677,444, dated Aug. 18, 2011.
40 Ceviker. N. et al.; A New Coated Bipolar Coagulator: Technical Note; 1998; Acta Neurochir (Wien).; 140 (6): 619-20; Department of Neurosurgery, Faculty of Medicine, Gazi University, Ankara, Turkey.
41 Cherchi. PL. et al.: Utility of Bipolar Electrocautery Scissors for Cervical Conization: 2002; Eur J Gynaecol Oncol. 2002; 23 (2): 154-6; Department of Pharmacology, Gynecology and Obstetrics, University of Sassari, Italy.
42 Chinese Application No. 200880005429.2, Second Office Action mailed Mar. 6, 2013 with English translation.
43 Chinese Application Serial No. 200880005429.2, First Office Action mailed Aug. 20, 2012.
44 Chinese Application Serial No. 200880005613.7, Second Office Action mailed Jan. 31, 2013, 11 pgs. (English Translation).
45 Chinese Application Serial No. 200880005613.7, Third Office Action mailed Aug. 30, 2013.
46 Chinese Notice of First Office Action with Text of Office Action issued in related Chinese Application No. 201180009484.0, dated Sep. 29, 2014.
47 Circon Corporation-Company Report; Investext, p. 1-13; Jan. 3, 1995.
48 Colvin. D.P. et al.: Development of an Endoscopic RF Hyperthermia System for Deep Tumor Therapy: 1987: American Society of Mechanical Engineers. Heat Transfer Division, (Publication) HTD v. 95. Publ by ASME (BED-v 7), New York, NY, USA p. 25-30.
49 Corson. S.L.: Two New Laparoscopic Instruments: Bipolar Sterilizing Forceps and Uterine Manipulator: Jan.-Feb. 1977; Medical Instrumentation vol. 11, No. 1 p. 7-8;; USA.
50 Daniel. P. et al.: Ultrasonic Sealing of the Lung Parenchyma After Atypical Resection: ZEXP Chir Transplant Kunstliche Organe. 1987: 20 (2): 117-21.
51 Digeronimo. EM et al.: Cut-Blot-Coagulate: A New Time Savino Device: Nov. 1982 Plast Reconstr Surg.; 70 (5): 639-40.
52 Dubuc-Lissoir. J.: Use of a New Energy-Based Vessel Ligation Device During Laparoscopic Gynecologic Oncologic Surgery: Mar. 2003 Surg Endosc.: 17 (3): 466-8.Epub Oct. 31, 2002; Department of Obstetrics and Gynecology, CHUM-Notre-Dame Hospital, Pavilion Charles-Simard, 2065 Alexandre-de-Seve, 4th Floor, Montreal, Quebec, Canada, H2L 2W5. josee.dubuc-lissoir.chum@ssss.gouv.qc.ca.
53 Eichfeld, "Evaluation of Ultracision in Lung Metastatic Surgery", Ann Thorac Surg, vol. 70, No. 4 (Oct. 2000), 1181-1184.
54 Entire patent prosecution history of U.S. Appl. No. 11/382,635, filed May 10, 2006, entitled, "Method for Tissue Cauterization," now U.S. Pat. No. 7,862,565, issued Jan. 4, 2011.
55 Entire patent prosecution history of U.S. Appl. No. 11/671,891, filed Feb. 6, 2007, entitled, "Electrocautery Method and Apparatus," now U.S. Pat. No. 8,696,662, issued Apr. 15, 2014.
56 Entire patent prosecution history of U.S. Appl. No. 11/671,911, filed Feb. 6, 2007, entitled, "Electrocautery Method and Apparatus," now U.S. Pat. No. 8,728,072, issued May 20, 2014.
57 Entire patent prosecution history of U.S. Appl. No. 12/062,516, filed Apr. 4, 2008, entitled, "Electrocautery Method and Apparatus."
58 Entire patent prosecution history of U.S. Appl. No. 12/121,734, filed May 15, 2008, entitled, "Electrocautery Method and Apparatus."
59 Entire patent prosecution history of U.S. Appl. No. 12/410,322, filed Mar. 24, 2009, entitled, "Electrocautery Method and Apparatus."
60 Entire patent prosecution history of U.S. Appl. No. 13/096,912, filed Apr. 28, 2011, entitled, "Apparatus for Tissue Cauterization," now U.S. Pat. No. 8,888,770, issued Nov. 18, 2014.
61 Ercoli. A. et al.: Radiofrequency Bipolar Coagulation for Radical Hysterectomy: Technique. Feasibility and Complications: Mar.-Apr. 2003 Int J Gynecol Cancer.: 13 (2):187-91 department of Obstetrics and Gynecology, Catholic University, Rome, Italy.
62 European Application Serial No. 08728715.7, European Examination Report dated Dec. 20, 2012.
63 European Patent Office Examination Report for Application No. EP 07 758 098.3 Dated Feb. 8, 2012.
64 European Search Report for Application No. PCT/US2008/052656 dated Mar. 30, 2012.
65 European Search Report issued in Application No. 11760294.6, dated Oct. 28, 2013.
66 Everest Medical Releases Bicoag (TM) for Use in Treating Bleeding Ulcers: May 9, 1990:News Release, p. 1.
67 Examination Report for Canadian Application No. 2,677,300 dated Mar. 28, 2012.
68 Examination Report for Canadian Application No. 2,677,444 dated Jul. 3, 2012.
69 Examination Report issued in Japanese Patent Application No. 2012 173318, dispatched on Aug. 26, 2013.
70 Examining Report issued in corresponding Japanese Patent Application No. 2011 509759, dispatched on Aug. 6, 2013.
71 Final Office Action dated Dec. 30, 2015 for U.S. Appl. No. 12/062,516.
72 Final Office Action for U.S. Appl. No. 12/062,516 dated Jul. 27, 2012.
73 Forestier D. et al.: Do Bipolar Scissors Increase Postoperative Adhesions? An Experimental Double-Blind Randomized Trial: Nov. 2002, Ann Chir.; 127 (9): 680-4; Service de chirurgie generale et digestive, Hotel-Dieu, boulevard Leon-Malfreyt, 63058 Clermont-Ferrand, France.
74 Gerasin VA et al.: Endoscopic Electrosurgery of the Trachea and Bronchi; Sep.-Oct. 1988 Grudn Khir; (5): 50-3.
75 Gyr. T. et al.: Minimal Invasive Laparoscopic Hysterectomy With Ultrasonic Scalpel: Jun. 2001 Am J Surg.; 181 (6): 516-9; Department of Obstetrics and Gynecology, Regional Hospital, Lugano, Switzerland.
76 Harrell. AG et al.: Energy Sources in Laparoscopy: Sep. 2004 Semin Laparosc Surg.; 11 (3): 201-9; Carolinas Laparoscopic and Advanced Surgery Program, Carolinas Medical Center, Charlotte, NC 28203, USA.
77 Hayashi, "Experimental and Clinical Evaluation of the Harmonic Scalpel in Thoracic Surgery", Kurume Med J, vol. 46, No. 1 (1999), 25-29.
78 Hefni, "Safety and Efficacy of using the Ligasure Vessel Sealing System for Securing the Pedicles in Vaginal Hysterectomy: Randomized Controlled Trial", BJOG, vol. 112, No. 3 (Mar. 2005), 329-333.
79 Heniford, "Initial Results with an Electrothermal Bipolar Vessel Sealer", Surg Endosc, vol. 15, No. 8 (Aug. 2001), 799-801.
80 Indian Examination Report issued in related Indian Application No. 2843/KOLNP/2009, dated Jul. 31, 2014.
81 Indian Examination Report issued in related Indian Application No. 4341/KOLNP/2007 dated Feb. 27, 2014.
82 International Application Serial No. PCT/US2011/029958, International Search Report dated Dec. 22, 2011.
83 Japanese Examination Report for Application No. 2009-549182, dated Oct. 27, 2011 with English translation.
84 Japanese Examination Report for Application No. 2009-549183, dated Oct. 27, 2011 with English translation.
85 Japanese Examination Report issued in related Japanese Application No. 2011-509759 dated Feb. 28, 2014.
86 Japanese Examination Report with English translation issued in related Japanese Application No. JP 2013-501509, dated Nov. 7, 2014.
87 Kamat, "Superiority of Electrocautery Over the Suture Method for Achieving Cervical Cone Bed Hemostasis", Obstet Gynecol, vol. 102, No. 4 (Oct. 2003), 726-730.
88 Kato. K. et al.: A Computer Based. Temperature Controlled Bipolar Electrocoagulation System: Sep. 1996 Eur J Obstet Gynecol Reprod Biol.; 68 (1-2): 119-22; Department of Obstetrics and Gynecology, University of Essen, Germany.
89 Kennedy, "High-Burst-Strength, Feedback-Controlled Bipolar Vessel Sealing", Surg Endosc, vol. 12, No. 6 (Jun. 1998), 876-878.
90 Kim, "Design and Fabrication of a Locomotive Mechanism for Capsule-Type Endoscopes using Shape Memory Alloys (SMAs)", IEEE/ASME Trans on Mechatronics, vol. 10, No. 1 (Feb. 2005), 77-86.
91 Koch. C. et al.: Determination of Temperature Elevation in Tissue During the Application of the Harmonic Scalpel; Feb. 2003 Ultrasound Med Biol.: 29 (2): 301-9: Ultrasonics Section, Physikalisch-Technische Bundesanstalt Braunschweig, B raunschweig, Germany. christian.koch@ptb.de.
92 Kohler C. et al.: Laparoscopic Coagulation of the Uterine Blood Supply in Laparoscopic-Assisted Vaginal Hysterectomy Is Associated With Less Blood Loss: 2004Eur J Gynaecol Oncol.; 25 (4): 453-6; Department of Gynecology, Friedrich Schiller University, Jena, Germany.
93 Korean Examination report issued in related Korean Application No. 10-2009-7018104 dated Feb. 20, 2014.
94 Koss et al.; U.S. Appl. No. 12/907,646 entitled "Impedance Mediated Control of Power Delivery for Electrosurgery," filed Oct. 19, 2010.
95 Kovac, "Transvaginal Hysterectomy: Rationale and Surgical Approach", Obstet. Gynecol., vol. 103 (2004), 1321-1325.
96 Kung. RC et al: A New Bipolar System for Performing Operative Hysetroscopy in Normal Saline; Aug. 1999; 6 (3): 331-6J Am Assoc Gynecol Laparosc.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=pubmed&dopt=Abstract& list uids=10459037&query hl=1.
97 Kwok. A. et al.: Comparison of Tissue Injury Between Laparosonic Coagulating Shears and Electrosurgical Scissors in the Sheep Model: Aug. 2001 J Am Assoc Gynecol Laparosc.; 8 (3): 378-84; Department of Endosurgery, Women's Institute, University of Sydney, Australia.
98 Landman, "Evaluation of a Vessel Sealing System, Bipolar Electrosurgery, Harmonic Scalpel, . . . in a Porcine Model", J Urol, vol. 169, No. 2 (Feb. 2003), 697-700.
99 Lantis. JC II et al.: Comparison of Coagulation Modalities in Surgery: Dec. 1998 J Laparoendosc Adv Surg Tech A.; 8 (6): 381-94; Surgical Research Laboratory, New England Medical Center, Boston, Massachusetts, USA.
100 Laparoscopic Lasers Vs. Electrosurgery: Debated Technology Choices: Jun. 6. 1991: The BBI Newsletter, v. 14, n. 6, pN/A.
101 Levy, "Update on Hysterectomy: New Technology and Techniques", A Supp to OBG Management (Feb. 2003).
102 Levy, "Use of a New Vessel Ligation Device During Vaginal Hysterectomy (presentation abstract)", Presented at FIGO 2000, Washington D.C. (2000).
103 Lin, "Application of Ultrasonic Scalpel in Gynecologic Operative Laparoscopy", Chin Med J (Engl), vol. 114, No. 12 (Dec. 2001), 1283-1285.
104 Lyons , "An Innovative Bipolar Instrument for Laparoscopic Surgery", JSLS, vol. 9, No. 1 (Jan.-Mar. 2005), 39-41.
105 Market and Technology Updates: Bipolar Endoscopic Device: Jan. 24. 1990: The BBI Newsletter, v. 13, n. 1, pN/A.
106 Matsumura Y. et al.: New Surgical Technique of Pulmonary Segmentectomy by Ultrasonic Scalpel and Absorbable Sealing Materials: Jan. 2004 Kyobu Geka.: 57 (1): 31-7; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
107 McClurken, "Collagen Shrinkage and Vessel Sealing", Technical Brief #300, Dover, NH, Tissue Link Medical (2001).
108 Mundt. C. et al.: Advanced Sensor Systems for Improved Labor and Fetal Monitoring: 1998; ISA TECH/EXPO Technology Update Conference Proceedings v. 2 n. 2, p. 79-89; 1998.
109 Nikolov, N. et al.; Remote Controllable Vessel Occlusion Device: Jan. 1978 Med Biol Eng Comput.; 16 (1): 116-7.
110 Nojarov, "High-Energy Scissors Mode", Phys Rev C Nucl Phys, vol. 51, No. 5, http://arxiv.org/abs/nucl-th/9502001v1, (1995), 2449-2456.
111 Non-Final Office Action mailed Sep. 28, 2015 for U.S. Appl. No. 12/121,734.
112 Notice of Allowance for U.S. Appl. No. 13/096,912, dated Jul. 25, 2014.
113 Office Action for U.S. Appl. No. 12/062,516 mailed Mar. 16, 2015.
114 Office Action for U.S. Appl. No. 12/121,734, dated Sep. 17, 2014.
115 Office Action mailed Jun. 8, 2015 for U.S. Appl. No. 12/410,322.
116 Ou. CS et al.: Total Laparoscopic Hysterectomy Using Multifunction Grasping. Coagulating, and Cutting Forceps: Apr. 2004 J Laparoendosc Adv Surg Tech A.; 14 (2): 67-71; Department of Research and Development, Northwest Hospital and University of Washington School of Medicine, Seattle, Washington 98155, USA. cou@nwhsea.org.
117 Parikh, "Three Dimensional Virtual Reality Model of the Normal Female Pelvic Floor", Annals of Bimedical Engineering, vol. 32 (Feb. 2004), 292-296.
118 Pavlov. IUV et al.: Ultrasonic Technologies in Diagnosis and Treatment of Patients With Surgical Diseases of Lungs and Pleura; 2003 Khirurgiia (Mosk).; (8): 30-4.
119 Petrakis. IE et al.: Use of the Ligasure Vessel Sealer in Total Abdominal Hysterectomy: Jun. 2005 Int J Gynaecol Obstet.; 89 (3): 303-4. Epub Mar. 2, 2005; Department of General Surgery, University General Hospital of Heraklion, University of Crete, Heraklion, Crete, Greece, petrakis@post.com.
120 Raestrup. H. et al.: Dissection Technique Is Ultrasound the Best Method?: 2001 Kongressbd Dtsch Ges Chir Kohgr.; 118; 69-70; Universitatsklinik Fur Allgemeine Chirurgie, Hoppe-Seyler-Strasse 3, 72076 Tubingen.
121 Robinson JL et al.: Bipolar Diathermy: Sep. 1974 Can J Surg.;-17 (5): 287-91.
122 Srisombut, "Laparoscopic Hysterectomy using Laparoscopic Coagulating Shears: Experience of 15 Cases", J. Med Assoc Thai, vol. 83, No. 8 (Aug. 2000), 915-920.
123 Stanojevic. D. et al.: An Ultrasonic Scalpel for Laparoscopic Gynecologic Surgery: May-Jun. 1998 Srp Arh Celok Lek.; 126 (5-6): 214-6; Narodni Front Department of Gynecology and Obstetrics, Dr. Dragisha Mishovitsh Medical Centre, Belgrade.
124 Sugi, K. et al.: Use of the Bipolar Vessel Sealing System in Lung Resection: Jul. 2003 Kyobu Geka.; 56 (7): 551-4; Department of Clinical Research, National Sanyo Hospital, Ube, Japan.
125 Tajiri M. et al.: Evaluation of an Ultrasonic Cutting and Coagulating System (Harmonic Scalpel) for Performing a Segmental and Wedge Resection of the Lung: Dec. 1998 Kyobu Geka.; 51 (13): 1116-9; Department of Surgery, Kan to Rosai Hospital, Kawasaki, Japan.
126 Tamussino. K. et al.: Electrosurgical Bipolar Vessel Sealing for Radical Abdominal Hysterectomy: Feb. 2005 Gynecol Oncol.: 96 (2): 320-2:Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, A-8036 Graz, Austria. Karl.tamussino@meduni-graz.at.
127 Timor-Tritsch IE et al.: Transvaginal Ultrasound-Assisted Gynecologic Surgery: Evaluation of a New Device to Improve Safety of Intrauterine Surgery; Oct. 2003 Am J Obstet Gynecol.; 189 (4); 1074-9; Department of Obstetrics and Gynecology, New York University School of Medicine, NY 10016, USA. ilan.timor@med.nyu.edu.
128 Tucker. R.D. et al.: Capacitive Coupled Stray Currents During Laparoscopic and Endoscopic Electrosurgical Procedures: Jul.-Aug. 1992: Biomedical Instrumentation & Technology vol. 26, No. 4 p. 303-11;; USA.
129 Tucker. RD et al.: Bipolar Electrosurgical Sphincterotomv: Gastrointest Endosc. Mar.-Apr. 1992 ; 38 (2): 113-7; Department of Pathology, University of Iowa Hospitals Clinics, Iowa City 52242.
130 U.S. Appl. No. 08/948,282, filed Oct. 9, 1997.
131 U.S. Appl. No. 12/200,798, filed Aug. 28, 2008.
132 U.S. Appl. No. 12/410,322, Non-Final Office Action mailed Oct. 17, 2012.
133 U.S. Appl. No. 12/748,229, filed Feb. 4, 2011.
134 U.S. Appl. No. 13/021,633, filed Feb. 4, 2011.
135 U.S. Appl. No. 13/070,391, filed Mar. 23, 2011.
136 U.S. Appl. No. 13/110,848, filed May 18, 2011.
137 Valley Force Scientific Corp.-Company Report: Jan. 27. 1993: Investext. p. 1-1.
138 Weyl. BP: How to Increase the Proportion of Vaginal Hysterectomies-Bipolar Coagulation: Sep. 1999 Am J Obstet Gynecol.; 181 (3): 768.
139 Wilson. Fred: Cool Tool. Hot New Application: Radiofrequency Energy Removes Head, Neck Tumors. (Dermatologic Surgery): Aug. 2003; Dermatology Times, v. 24, n. 8, p. 54.
140 Zhi, Xu-Ting et al.; Management of Gastroesophageal Reflux Disease. Medications. Surgery. Or Endoscopic Therapy? (Current Status and Trends): 2005: Journal of Long-Term Effects of Medical Implants v. 15 n. 4 2005. p. 375-388g.
Classification internationale A61B18/12, A61B18/18, A61B18/00, A61B18/14
Classification coopérative A61B2018/00595, A61B18/1445, A61B2018/00642, A61B2018/00678, A61B18/18, A61B18/1206, A61B2018/0063, A61B2018/00702, A61B2018/00589, A61B2018/00875
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KOSS, TIM;TAIMISTO, MIRIAM H.;VARNER, ROSEANNE;SIGNING DATES FROM 20121104 TO 20130118;REEL/FRAME:029679/0026